Weed control methods and related compositions and plants

By introducing recombinant polynucleotides into crop plants to modify FatA acyl-ACP thioesterase and express other herbicide tolerance enzymes, the problem of insufficient plant tolerance to herbicides was solved, achieving selective control and enhanced tolerance to herbicides that inhibit FatA acyl-ACP thioesterase.

CN118901567APending Publication Date: 2024-11-08SYNGENTA CROP PROTECITON AG
View PDF 2 Cites 0 Cited by

Patent Information

Application Number
CN202410947522.6
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Priority Date
2019-11-01
Filing Date
2020-10-26
Publication Date
2024-11-08

AI Technical Summary

Technical Problem

Existing technologies have limited ability to improve plant tolerance to herbicides, particularly to certain herbicides, through overexpression or modification of FatA acyl-ACP thioesterase.

Method used

By introducing recombinant polynucleotides into crop plants to modify their FatA acyl-ACP thioesterase, they are made resistant to FatA acyl-ACP thioesterase-inhibiting herbicides. Combined with the expression of other herbicide-resistant enzymes such as 5-enolpyruvate-shikimate-3-phosphate synthase (EPSPS), glyphosate acetyltransferase (GAT), cytochrome P450, glufosinate acetyltransferase (PAT), acetolactate synthase (ALS), protoporphyrinogen oxidase (PPO), and dicamba degrading enzyme, resistance to multiple herbicides is achieved.

Benefits of technology

It achieves selective control of FatA acyl-ACP thioesterase-inhibiting herbicides, improves crop tolerance to herbicides, reduces the amount of herbicide used, and lowers the risk of crop toxicity.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118901567A_ABST
    Figure CN118901567A_ABST
Patent Text Reader

Abstract

The present disclosure relates, inter alia, to weed control methods. In one example, a method comprises applying to a locus a weed control amount of a pesticidal composition comprising a FatA acyl-ACP thioesterase inhibiting herbicide wherein crop plants are modified such that they comprise a FatA acyl-ACP thioesterase, and wherein the FatA acyl-ACP thioesterase is modified such that they comprise a FatA acyl-ACP thioesterase. The FatA acyl-ACP thioesterase enzymes provide the crop plant with tolerance to the FatA acyl-ACP thioesterase enzyme inhibiting herbicide. Also disclosed are recombinant polynucleotides, and which are suitable for use in the methods, as well as edited FatA acyl-ACP thioesterases.
Need to check novelty before this filing date? Find Prior Art

Description

[0001] This application is a divisional application of an invention patent application with an application date of October 26, 2020, application number 202080073866.9, and invention name “Weed control methods and related compositions and plants”. Technical Field

[0002] The present disclosure relates generally to the field of biotechnology, and more specifically to recombinant and genetic engineering techniques for expressing FatA acyl-ACP thioesterases or modifications thereof that provide tolerance to certain herbicides.

[0003] Statement Regarding Electronically Submitted Sequence Listings

[0004] Provided herein is a sequence listing in ASCII text format, which was submitted pursuant to 37 CFR §1.821, named "81983_PCT_ST25.txt", generated on October 31, 2019 and submitted via EFS-Web. This sequence listing is hereby incorporated into this specification by reference for its disclosure content. Background Art

[0005] It has been widely reported that crop engineering approaches are used to become tolerant to herbicides and thus the use of some herbicides is expanded to other crops using herbicide tolerance transgenics. Herbicide tolerance can be conferred by overexpression of the gene encoding the herbicide target protein and / or by the expression of the transgenics of the target site that changes and is insensitive to herbicides (for example, in the case of glyphosate tolerance, the insensitive 5-enol pyruvyl shikimate-3-phosphate synthase of glyphosate) and / or by the expression of the enzyme that herbicides are metabolized into inactive forms (for example, in the case of glufosinate tolerance, glufosinate N-acetyltransferase). Similarly, in situ mutagenesis (directed or otherwise) has been used for mutation, for example acetolactate synthase (ALS) or acetyl-CoA carboxylase (ACCase) herbicide target genes, to produce a crop strain of mutant tolerant herbicides. In addition to early examples of tolerance to the non-selective herbicides glyphosate and glufosinate, there are now numerous reports of transgenes and methods for conferring herbicide tolerance to other herbicides, such as those that act by inhibiting 4-hydroxyphenylpyruvate dioxygenase (HPPD), protoporphyrinogen oxidase (PPO), and several auxin-type herbicides, notably dicamba and 2,4D. Despite this, applicants continue to work hard to develop new technologies for herbicide resistance.

[0006] In higher plants, fatty acid biosynthesis is catalyzed by type II fatty acid synthase (FASII) located in the plastids. FASII catalyzes the condensation of malonyl-ACP (acyl carrier protein) with acyl-ACP derivatives, continuously elongating the growing acyl-ACP chain with two carbon units, which is finally terminated by the hydrolysis of the thioester bond of acyl-ACP catalyzed by acyl-ACP thioesterase, releasing free fatty acids, which are quickly re-esterified by acyl-CoA synthetase and exported to the cytosol. Plant acyl-ACP thioesterases are nuclear-encoded plastid-targeted proteins. There are two gene families: FatA and FatB, of which FatA is localized in the plastids and encodes a thioesterase with high specificity for 18:1-ACP and lower activity for 18:0-ACP and 16:0-ACP.

[0007] Overexpression of FatA acyl-ACP thioesterase in transgenic plants has been reported, for example, in US 2013 / 0298283, wherein the plants are said to exhibit improved tolerance to water deficiency. However, FatA acyl-ACP thioesterase or its modifications have not been used to increase tolerance to certain classes of herbicidal compounds. Therefore, the present disclosure provides, among other things, the opportunity to utilize FatA acyl-ACP thioesterase-inhibiting herbicides in a broader agricultural context. Summary of the invention

[0008] The present disclosure relates particularly to methods for selectively controlling weeds. For example, embodiments include methods for selectively controlling weeds at a site comprising crop plants and weeds, the method comprising applying a weed control amount of a pesticide composition to the site, the pesticide composition comprising a FatA acyl-ACP thioesterase-inhibiting herbicide (also referred to herein as a "FatA-inhibiting herbicide"), wherein the crop plants are modified so that they comprise a FatA acyl-ACP thioesterase that provides tolerance to the FatA-inhibiting herbicide for the crop plants. In one embodiment, the crop plants are modified with a recombinant polynucleotide that provides a FatA acyl-ACP thioesterase that provides tolerance to the FatA acyl-ACP thioesterase-inhibiting herbicide for the crop plants. FatA acyl-ACP thioesterase can be derived from a variety of species, such as Arabidopsis species, Triticum species, Hordeum species, Oryza species, Zea species, and Glycine max species. In some examples, FatA acyl-ACP thioesterase is derived from Arabidopsis thaliana, Triticum aestivum (Wheat), Hordeum vulgare, Barley, Oryza sativa, Rice, Zea mays, Maize, or Glycinemax, Soybean.

[0009] In one embodiment of the method, the FatA acyl-ACP thioesterase is selected from: (a) the group consisting of SEQ ID NOs: 1-7 and 15-19; or (b) a FatA acyl-ACP thioesterase having at least one of a sequence identity of at least 70%, at least 71%, at least 72%, at least 73%, at least 74%, at least 75%, at least 76%, at least 77%, at least 78%, at least 79%, at least 80%, at least 81%, at least 82%, at least 83%, at least 84%, at least 85%, at least 86%, at least 87%, at least 88%, at least 89%, at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98%, and at least 99% to a sequence selected from SEQ ID NOs: 1-7 and 15-19. In many embodiments, the FatA acyl-ACP thioesterase will include at least a first amino acid substitution selected from the group consisting of S76 (G, A, L, M, F, W, K, Q, E, P, V, I, C, Y, H, R, N, D, T), L77 (G, A, M, F, W, K, Q, E, S, P, V, I, C, Y, H, R, N, D, T), T78 (G, A, L, M, F, W, K, Q, E, S, P, V, I, C, Y, H, R, N, D), D80(G,A,L,M,F,W,K,Q,E,S,P,V,I,C,Y,H,R,N,T),G81(A,L,M,F,W,K,Q,E,S,P,V,I,C,Y,H,R,N,D,T),L8 2(G,A,M,F,W,K,Q,E,S,P,V,I,C,Y,H,R,N,D,T),S83(G,A,L,M,F,W,K,Q,E,P,V,I,C,Y,H,R,N,D,T),Y84(G ,A,L,M,F,W,K,Q,E,S,P,V,I,C,H,R,N,D,T),K85(G,A,L,M,F,W,Q,E,S,P,V,I,C,Y,H,R,N,D,T),E86(G,A ,L,M,F,W,K,Q,S,P,V,I,C,Y,H,R,N,D,T),F88(G,A,L,M,W,K,Q,E,S,P,V,I,C,Y,H,R,N,D,T),I106(G,A,L ,M,F,W,K,Q,E,S,P,V,C,Y,H,R,N,D,T),A107(G,L,M,F,W,K,Q,E,S,P,V,I,C,Y,H,R,N,D,T),N108(G,A,L ,M,F,W,K,Q,E,S,P,V,I,C,Y,H,R,D,T),L109(G,A,M,F,W,K,Q,E,S,P,V,I,C,Y,H,R,N,D,T),L110(G,A,M,F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、Q111(G、A、L、M、F、W、K、E、S、P、V、I、C、Y、H、R、N、D、T)、E112(G、A、L、M、F、W、K、Q、S、P、V、I、C、Y、H、R、N、D、T)、V113(G、A、L、M、F、W、K、Q、E、S、P、I、C、Y、H、R、N、D、T)、G114(A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、C115(G、A、L、M、F、W、K、Q、E、S、P、V、I、Y、H、R、N、D、T)、N116(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、D、T)、H117(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、R、N、D、T)、A118(G、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、Q119(G、A、L、M、F、W、K、E、S、P、V、I、C、Y、H、R、N、D、T)、S120(G、A、L、M、F、W、K、Q、E、P、V、I、C、Y、H、R、N、D、T)、V121(G、A、L、M、F、W、K、Q、E、S、P、I、C、Y、H、R、N、D、T)、G122(A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、F123(G、A、L、M、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、S124(G、A、L、M、F、W、K、Q、E、P、V、I、C、Y、H、R、N、D、T)、T125(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D)、D126(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、T)、G127(A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、F128(G、A、L、M、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、A129(G、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、T130(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D)、T131(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D)、T132(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D)、T133(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D)、M134(G、A、L、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、R135(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、N、D、T)、L139(G、A、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、I140(G、A、L、M、F、W、K、Q、E、S、P、V、C、Y、H、R、N、D、T)、W141(G、A、L、M、F、K、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、V142(G、A、L、M、F、W、K、Q、E、S、P、I、C、Y、H、R、N、D、T)、T143(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D)、A144(G、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、R145(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、N、D、T)、M146(G、A、L、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、H147(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、R、N、D、T)、I162(G、A、L、M、F、W、K、Q、E、S、P、V、C、Y、H、R、N、D、T)、E163(G、A、L、M、F、W、K、Q、S、P、V、I、C、Y、H、R、N、D、T)、T164(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D)、W165(G、A、L、M、F、K、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、C166(G、A、L、M、F、W、K、Q、E、S、P、V、I、Y、H、R、N、D、T)、Q167(G、A、L、M、F、W、K、E、S、P、V、I、C、Y、H、R、N、D、T)、S168(G、A、L、M、F、W、K、Q、E、P、V、I、C、Y、H、R、N、D、T)、E169(G、A、L、M、F、W、K、Q、S、P、V、I、C、Y、H、R、N、D、T)、G170(A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、R171(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、N、D、T)、I172(G、A、L、M、F、W、K、Q、E、S、P、V、C、Y、H、R、N、D、T)、G173(A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、T174(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D)、R175(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、N、D、T)、R176(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、N、D、T)、D177(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、T)、W178(G、A、L、M、F、K、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、R191(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、N、D、T)、A192(G、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、T193(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D)、S194(G、A、L、M、F、W、K、Q、E、P、V、I、C、Y、H、R、N、D、T)、K195(G、A、L、M、F、W、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、W196(G、A、L、M、F、K、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、V197(G、A、L、M、F、W、K、Q、E、S、P、I、C、Y、H、R、N、D、T)、M198(G、A、L、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、M199(G、A、L、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、Q207(G、A、L、M、F、W、K、E、S、P、V、I、C、Y、H、R、N、D、T)、V209(G、A、L、M、F、W、K、Q、E、S、P、I、C、Y、H、R、N、D、T)、S210(G、A、L、M、F、W、K、Q、E、P、V、I、C、Y、H、R、N、D、T)、D212(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、T)、V213(G、A、L、M、F、W、K、Q、E、S、P、I、C、Y、H、R、N、D、T)、R214(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、N、D、T)、D215(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、T)、E216(G、A、L、M、F、W、K、Q、S, P, V, I, C, Y, H, R, N, D, T), Y217 (G, A, L, M, F, W, K, Q, E, S, P, V, I, C, H, R, N, D, T), L218 (G, A, M, F, W, K, Q, E, S, P, V, I, C, Y ,H,R,N,D,T),V219(G,A,L,M,F,W,K,Q,E,S,P,I,C,Y,H,R,N,D,T),F220(G,A,L,M,W,K,Q,E,S,P,V,I,C,Y,H,R,N,D,T) ,C221(G,A,L,M,F,W,K,Q,E,S,P,V,I,Y,H,R,N,D,T),P222(G,A,L,M,F,W,K,Q,E,S,V,I,C,Y,H,R,N,D,T),Q223(G,A,L ,M,F,W,K,E,S,P,V,I,C,Y,H,R,N,D,T),R226(G,A,L,M,F,W,K,Q,E,S,P,V,I,C,Y,H,N,D,T),D262(G,A,L,M,F,W,K,Q,E ,S,P,V,I,C,Y,H,R,N,T),M263(G,A,L,F,W,K,Q,E,S,P,V,I,C,Y,H,R,N,D,T),N264(G,A,L,M,F,W,K,Q,E,S,P,V,I,C, Y, H, R, D, T), H266 (G, A, L, M, F, W, K, Q, E, S, P, V, I, C, Y, R, N, D, T), V267 (G, A, L, M, F, W, K, Q, E, S, P, I, C, Y, H, R, N, D, T), N268 (G, A, L, M, F, W, K, Q, E, S, P, V, I, C, Y, H, R, D, T), N269 (G, A, L, M, F, W, K, Q, E, S, P, V, I, C, Y, H, R, N, D, T), V270 (G, A, L, M, F, W, K, Q, E, S, P, I, C, Y, H, R, N, D, T), and Y297 (G, A, L, M, F, W, K, Q, E, S, P, V, I, C, H, R, N, D, T), wherein the position of the amino acid substitution is relative to the position of the amino acid sequence provided as SEQ ID NO:1. For example, the S at the position corresponding to position 76 of SEQ ID NO: 1 can be replaced with any of the following amino acids: G, A, L, M, F, W, K, Q, E, P, V, I, C, Y, H, R, N, D, or T. In another embodiment, the FatA acyl-ACP thioesterase comprises at least a first amino acid substitution selected from the group consisting of R176A, R176C, R176V, Y217L, L218C, S168R, G114S, F123N, R191C,C221F, N269Y, F123C, S168C, F220H, V121N, N269W, A118V and A144Y, wherein the position of the amino acid substitution is relative to the position of the amino acid sequence provided as SEQ ID NO: 1. In another embodiment, the FatA acyl-ACP thioesterase comprises at least 2, at least 3, at least 4, at least 5, at least 6 or at least 7 of the amino acid substitutions R176A, R176C, R176V, Y217L, L218C, S168R, G114S, F123N, R191C, C221F, N269Y, F123C, S168C, F220H, V121N, N269W, A118V and A144Y, wherein the position of the amino acid substitution is relative to the position of the amino acid sequence provided as SEQ ID NO: 1. In another embodiment, the FatA acyl-ACP thioesterase comprises at least one pair of amino acid substitutions selected from the group consisting of R176A and R191C, R176C and R191C, and R176V and R191C, wherein the position of the amino acid substitution is relative to the position of the amino acid sequence provided as SEQ ID NO: 1.

[0010] In some embodiments, the FatA acyl-ACP thioesterase is provided by editing an endogenous gene.

[0011] The FatA acyl-ACP thioesterase inhibiting herbicide may vary, but many examples will be selected from the group consisting of compounds of formula (I):

[0012]

[0013] Where R 1 and R 2 Each independently is H, C 1 -C 6 Alkyl, C 1 -C 6 Haloalkyl, halogen or cyano, preferably Me, Cl, F or H. Exemplary herbicides include cyproconazole and oxazithromycin.

[0014] Furthermore, in many embodiments of the method, the crop plant comprises a recombinant polynucleotide encoding an additional herbicide tolerance enzyme, wherein the additional herbicide tolerance enzyme is selected from the group consisting of: 5-enolpyruvylshikimate-3-phosphate synthase (EPSPS), glyphosate acetyltransferase (GAT), cytochrome P450, phosphinothricin acetyltransferase (PAT), acetolactate synthase (ALS), protoporphyrinogen oxidase (PPO), hydroxyphenylpyruvate dioxygenase (HPPD), and a dicamba degrading enzyme. Thus, the one or more additional herbicides may include glyphosate (including agrochemically acceptable salts thereof); glufosinate (including agrochemically acceptable salts thereof); chloroacetanilides, for example, alachlor, acetochlor, isopropyl metolachlor, S-isopropyl metolachlor; photosystem II inhibitors, for example, triazines such as ametryn, atrazine, cyanazine and terbuthylazine, triazinones such as hexazinone and metribuzin, and ureas such as chlorotoluron, diuron, isoproturon, linuron and butylthiocarb; ALS-inhibitors, for example, sulfonylureas such as acylosulfuron, chlorosulfuron, fluazifop-methyl, clopyrasulfuron, nicosulfuron, primisulfuron, prosulfuron, rimsulfuron, etherbensulfuron-methyl, trifloxysulfuron and trifloxysulfuron; diphenyl ethers, for example, acifluorfen and fomesafen; HPPD-inhibiting herbicides, such as mesotrione and flupyralidone; dicamba and 2,4D.

[0015] The present disclosure also relates to recombinant polynucleotides. In one embodiment, the recombinant polynucleotide comprises a region encoding a FatA acyl-ACP thioesterase, which region is operably linked to a plant operable promoter. In one embodiment, the FatA acyl-ACP thioesterase is selected from the group consisting of: SEQ ID NO: 8-14, or SEQ ID NO: 20-23, or a DNA sequence encoding a FatA acyl-ACP thioesterase comprising at least a first amino acid substitution selected from the group consisting of S76 (G, A, L, M, F, W, K, Q, E, P, V, I, C, Y, H, R, N, D, T), L77 (G, A, M, F, W, K, Q, E, S, P, V, I, C, Y, H, R, N, D, T), T78 (G, A, L, M, F, W, K, Q, E, S, P, V, I, C, Y, H, R, N, D), D80 (G, A, L, M, F, W, K, Q, E, S, P, V, I, C, Y, H, R, N, T), G81 (A, L, M, F, W, K, Q, E, S, P, V, I, C, Y, H, R, N, D, T), L82 (G, A, M, F, W, K, Q, E, S, P, V, I, C, Y, H, R, N, D, T), S83 (G, A, L, M ,F,W,K,Q,E,P,V,I,C,Y,H,R,N,D,T),Y84(G,A,L,M,F,W,K,Q,E,S,P,V,I,C,H,R,N,D,T),K85(G,A,L,M,F,W,Q,E,S,P,V,I,C,Y,H,R ,N,D,T),E86(G,A,L,M,F,W,K,Q,S,P,V,I,C,Y,H,R,N,D,T),F88(G,A,L,M,W,K,Q,E,S,P,V,I,C,Y,H,R,N,D,T),I106(G,A,L,M,F, W, K, Q, E, S, P, V, C, Y, H, R, N, D, T), A107 (G, L, M, F, W, K, Q, E, S, P, V, I, C, Y, H, R, N, D, T), N108 (G, A, L, M, F, W, K, Q, E, S, P, V, I, C, Y, H, R,D,T),L109(G,A,M,F,W,K,Q,E,S,P,V,I,C,Y,H,R,N,D,T),L110(G,A,M,F,W,K,Q,E,S,P,V,I,C,Y,H,R,N,D,T),Q111(G,A,L,M,F, W, K, E, S, P, V, I, C, Y, H, R, N, D, T), E112 (G, A, L, M, F, W, K, Q, S, P, V, I, C, Y, H, R, N, D, T), V113 (G, A, L, M, F, W, K, Q, E, S, P, I, C, Y, H, R,N、D、T)、G114(A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、C115(G、A、L、M、F、W、K、Q、E、S、P、V、I、Y、H、R、N、D、T)、N116(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、D、T)、H117(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、R、N、D、T)、A118(G、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、Q119(G、A、L、M、F、W、K、E、S、P、V、I、C、Y、H、R、N、D、T)、S120(G、A、L、M、F、W、K、Q、E、P、V、I、C、Y、H、R、N、D、T)、V121(G、A、L、M、F、W、K、Q、E、S、P、I、C、Y、H、R、N、D、T)、G122(A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、F123(G、A、L、M、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、S124(G、A、L、M、F、W、K、Q、E、P、V、I、C、Y、H、R、N、D、T)、T125(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D)、D126(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、T)、G127(A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、F128(G、A、L、M、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、A129(G、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、T130(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D)、T131(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D)、T132(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D)、T133(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D)、M134(G、A、L、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、R135(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、N、D、T)、L139(G、A、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、I140(G、A、L、M、F、W、K、Q、E、S、P、V、C、Y、H、R、N、D、T)、W141(G、A、L、M、F、K、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、V142(G、A、L、M、F、W、K、Q、E、S、P、I、C、Y、H、R、N、D、T)、T143(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D)、A144(G、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、R145(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、N、D、T)、M146(G、A、L、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、H147(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、R、N、D、T)、I162(G、A、L、M、F、W、K、Q、E、S、P、V、C、Y、H、R、N、D、T)、E163(G、A、L、M、F、W、K、Q、S、P、V、I、C、Y、H、R、N、D、T)、T164(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D)、W165(G、A、L、M、F、K、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、C166(G、A、L、M、F、W、K、Q、E、S、P、V、I、Y、H、R、N、D、T)、Q167(G、A、L、M、F、W、K、E、S、P、V、I、C、Y、H、R、N、D、T)、S168(G、A、L、M、F、W、K、Q、E、P、V、I、C、Y、H、R、N、D、T)、E169(G、A、L、M、F、W、K、Q、S、P、V、I、C、Y、H、R、N、D、T)、G170(A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、R171(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、N、D、T)、I172(G、A、L、M、F、W、K、Q、E、S、P、V、C、Y、H、R、N、D、T)、G173(A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、T174(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D)、R175(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、N、D、T)、R176(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、N、D、T)、D177(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、T)、W178(G、A、L、M、F、K、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、R191(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、N、D、T)、A192(G、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、T193(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D)、S194(G、A、L、M、F、W、K、Q、E、P、V、I、C、Y、H、R、N、D、T)、K195(G、A、L、M、F、W、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、W196(G、A、L、M、F、K、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、V197(G、A、L、M、F、W、K、Q、E、S、P、I、C、Y、H、R、N、D、T)、M198(G、A、L、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、M199(G、A、L、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、Q207(G、A、L、M、F、W、K、E、S、P、V、I、C、Y、H、R、N、D、T)、V209(G、A、L、M、F、W、K、Q、E、S、P、I、C、Y、H、R、N、D、T)、S210(G、A、L、M、F、W、K、Q、E、P、V、I、C、Y、H、R、N、D、T)、D212(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、T)、V213(G、A、L、M、F、W、K、Q、E、S、P、I、C、Y、H、R、N、D、T)、R214(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、N、D、T)、D215(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、T)、E216(G、A、L、M、F、W、K、Q、S、P、V、I、C、Y、H、R、N、D、T)、Y217(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、H、R、N、D、T)、L218(G、A、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、V219(G、A、L、M、F、W、K、Q、E、S、P、I、C、Y、H、R、N、D、T)、F220 (G, A, L, M, W, K, Q, E, S, P, V, I, C, Y, H, R, N, D, T), C221 (G, A, L, M, F, W, K, Q, E, S, P, V, I, Y, H, R, N, D, T), P222 (G, A, L, M, F, W, K, Q, E, S, V, I, C, Y, H, R, N, D, T), Q223 (G, A, L, M, F, W, K, E, S, P, V, I, C, Y, H, R, N, D, T), R226 (G, A, L, M, F, W, K, Q, E, S, P, V, I, C, Y, H, N, D, T), D262 (G, A, L, M, F, W, K, Q, E, S, P, V, I, C, Y, H, R, N, T), M263 (G, A, L, F, W, K, Q, E, S, P, V, I, C, Y, H, R, N, D, T), N264 (G, A, L, M, F, W, K, Q, E, S, P, V, I, C, Y, H, R, D, T), H266 (G, A, L, M, F, W, K, Q, E, S, P, V, I, C, Y, R, N, D, T), V26 7(G,A,L,M,F,W,K,Q,E,S,P,I,C,Y,H,R,N,D,T), N268(G,A,L,M,F,W,K,Q,E,S,P,V,I,C,Y,H,R, N269 (G, A, L, M, F, W, K, Q, E, S, P, V, I, C, Y, H, R, N, D, T), V270 (G, A, L, M, F, W, K, Q, E, S, P, I, C, Y, H, R, N, D, T), and Y297 (G, A, L, M, F, W, K, Q, E, S, P, V, I, C, H, R, N, D, T), wherein the position of the amino acid substitution is relative to the position of the amino acid sequence provided as SEQ ID NO: 1; or encodes a FatA acyl group including at least a first amino acid substitution. ACP thioesterase DNA sequence, the amino acid substitution is selected from the group consisting of: R176A, R176C, R176V, Y217L, L218C, S168R, G114S, F123N, R191C, C221F, N269Y, F123C, S168C, F220H, V121N, N269W, A118V and A144Y, wherein the position of the amino acid substitution is relative to the position of the amino acid sequence provided as SEQ ID NO: 1.

[0016] In some embodiments of the recombinant polynucleotide, the FatA acyl-ACP thioesterase comprises at least 2, at least 3, at least 4, at least 5, at least 6, or at least 7 of the amino acid substitutions R176A, R176C, R176V, Y217L, L218C, S168R, G114S, F123N, R191C, C221F, N269Y, F123C, S168C, F220H, V121N, N269W, A118V, and A144Y, wherein the position of the amino acid substitution is relative to the position of the amino acid sequence provided as SEQ ID NO: 1. In another embodiment, the FatA acyl-ACP thioesterase comprises an amino acid substitution selected from the group consisting of R176A-R191C, R176C-R191C, and R176V-R191C, wherein the position of the amino acid substitution is relative to the position of the amino acid sequence provided as SEQ ID NO:1.

[0017] Embodiments of the recombinant polynucleotide may further include at least one additional region operably linked to a plant operable promoter, the region encoding a herbicide tolerance enzyme selected from the group consisting of: hydroxyphenylpyruvate dioxygenase (HPPD), 5-enolpyruvylshikimate-3-phosphate synthase (EPSPS), glyphosate acetyltransferase (GAT), cytochrome P450, phosphinothricin acetyltransferase (PAT), acetolactate synthase (ALS), protoporphyrinogen oxidase (PPO), hydroxyphenylpyruvate dioxygenase (HPPD) and dicamba degrading enzyme.

[0018] The present disclosure also relates to plant cells that are tolerant to FatA acyl-ACP thioesterase-inhibiting herbicides. The plant cell may comprise any recombinant polynucleotide as described herein or a DNA sequence encoding a FatA acyl-ACP thioesterase comprising any amino acid substitution described herein.

[0019] The present disclosure also relates to FatA acyl-ACP thioesterases, e.g., those that are not native or non-naturally occurring. For example, a native FatA acyl-ACP thioesterase has been modified to comprise any amino acid substitution described herein.

[0020] In another embodiment, the present disclosure relates to a recombinant polynucleotide comprising: a nucleic acid encoding a DNA modification enzyme; and a nucleic acid encoding at least one guide RNA (gRNA), wherein the at least one guide RNA mediates at least one modification to a FatA acyl-ACP thioesterase (e.g., by editing a DNA encoding the FatA acyl-ACP thioesterase).

[0021] In one embodiment, at least one gRNA mediates any amino acid substitution described herein.

[0022] In another embodiment, the present disclosure relates to a method for producing a plant tolerant to a FatA acyl-ACP thioesterase-inhibiting herbicide by transforming a recombinant polynucleotide into a plant cell or plant tissue, wherein the recombinant polynucleotide comprises a nucleic acid encoding a DNA modification enzyme, and a nucleic acid encoding at least one guide RNA (gRNA), wherein the at least one guide RNA mediates at least one modification of a FatA acyl-ACP thioesterase (e.g., by modifying a DNA encoding a protein); and regenerating the plant cell or plant tissue into a TO plant having a T1 seed, wherein the T1 seed can be regenerated to produce an edited plant tolerant to a FatA acyl-ACP thioesterase-inhibiting herbicide.

[0023] In another embodiment, the present disclosure relates to the use of a recombinant FatA acyl-ACP thioesterase in an in vitro screening method for identifying FatA acyl-ACP thioesterase inhibiting herbicides.

[0024] The above summary of the invention is intended to summarize certain embodiments of the present disclosure. The embodiments will be described in more detail in the tables and descriptions below. However, it will be clear that the detailed description of specific embodiments is not intended to limit the scope of the present invention. BRIEF DESCRIPTION OF THE DRAWINGS

[0025] Figure 1 is an illustration of a binary vector used for tobacco transformation to produce transgenic plants resistant to FatA acyl-ACP thioesterase inhibiting herbicides.

[0026] Figure 2 is an illustration of a binary vector used to create double mutants in the maize FatA acyl-ACP thioesterase to create edited plants resistant to FatA acyl-ACP thioesterase-inhibiting herbicides.

[0027] Brief Description of Sequence Listing

[0028] DETAILED DESCRIPTION

[0029] As noted above, it should be understood that the composition and method details herein are for the purpose of describing embodiments of the disclosure and are not intended to limit the disclosure or any invention thereof, the scope of which is determined by the claims.

[0030] The present disclosure is particularly related to methods for selectively controlling weeds at a site. The present disclosure further relates to recombinant DNA technology, and particularly to the production of transgenic plants that show significant resistance or significant tolerance to herbicides when compared with non-transgenic plants. The present disclosure further relates to gene editing technology, and particularly to the production of gene-edited plants that show significant resistance or significant tolerance to herbicides when compared with non-transgenic plants. The dose / response curve provided by plants that are basically "tolerant" to herbicides (when they are subjected to herbicides) is shifted to the right compared to that provided by non-tolerant plants of similar experience. Such dose / response curves plot "dose" on the x-axis and "kill percentage", "herbicidal effect" etc. on the y-axis. In order to produce a given herbicidal effect, tolerant plants typically require almost at least twice the herbicide of non-tolerant plants. Plants that are basically "resistant" to herbicides rarely (if ever) show necrosis, cracking, chlorosis or other lesions when experiencing herbicides at concentrations and ratios typically used by agricultural communities to kill field weeds.

[0031] Selective methods of weed control

[0032] According to the present disclosure, a method for selectively controlling weeds at a locus comprising crop plants and weeds is provided, the method comprising applying to the locus a weed controlling amount of a pesticide composition comprising a FatA acyl-ACP thioesterase inhibiting herbicide, wherein the crop plants are modified so that they contain a FatA acyl-ACP thioesterase that provides the crop plants with tolerance to the FatA acyl-ACP thioesterase inhibiting herbicide.

[0033] For the purposes of the present invention, a FatA acyl-ACP thioesterase inhibiting herbicide is one that inhibits Arabidopsis thaliana FatA acyl-ACP thioesterase (ie, exhibits an IC50 of less than 10 μM, preferably 5 μM, in an assay as described herein).

[0034] Crop plants can be modified in a variety of ways. In one embodiment, these crop plants are modified with recombinant polynucleotides, which provide the FatA acyl-ACP thioesterase, which provides tolerance to the FatA acyl-ACP thioesterase inhibitory herbicides for the crop plants. FatA acyl-ACP thioesterase can be derived from a variety of species, such as Arabidopsis species, Triticum species, Hordeum species, Oryza species, Zea species and Glycine species. In some instances, FatA acyl-ACP thioesterase is derived from Arabidopsis thaliana, Triticum aestivum (wheat), Hordeum vulgare (Barley), Oryza sativa (Rice), Zea mays (Maize) or soybean (Glycine max, Soybean).

[0035] In one embodiment, the FatA acyl-ACP thioesterase is selected from the group consisting of: (a) SEQ ID NOs: 1-7 and 15-19; or (b) a FatA acyl-ACP thioesterase having at least one of 70%, at least 71%, at least 72%, at least 73%, at least 74%, at least 75%, at least 76%, at least 77%, at least 78%, at least 79%, at least 80%, at least 81%, at least 82%, at least 83%, at least 84%, at least 85%, at least 86%, at least 87%, at least 88%, at least 89%, at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98%, and at least 99% sequence identity to a sequence selected from SEQ ID NOs: 1-7 and 15-19. "Identity" or "percent identity" refers to the degree of identity between two nucleic acid or amino acid sequences. For sequence comparison, typically, one sequence serves as a reference sequence for comparison with a test sequence. When using a sequence comparison algorithm, the test sequence and reference sequence are input into a computer (if necessary, subsequence coordinates are specified), and the parameters of the sequence algorithm program are specified. Then, the sequence comparison algorithm calculates the sequence identity percentage of this or these test sequences relative to the reference sequence based on the specified program parameters.

[0036] Optimal alignment of sequences for comparison can be performed, for example, by the local homology algorithm of Smith and Waterman, Adv. Appl. Math. 2:482 (1981), by the homology alignment algorithm of Needleman and Wunsch, J. Mol. Biol. 48:443 (1970), by the search by similarity method of Pearson and Lipman, Proc. Nat′l. Acad Sci. USA 85:2444 (1988), by computerized implementations of these algorithms (GAP, BESTFIT, FASTA, and TFASTA in the Wisconsin Genetics Analysis Software Package, Genetics Computer Group, 575 Science Dr., Madison, Wisconsin), or by visual inspection. An example of an algorithm that is suitable for determining percent sequence identity and sequence similarity is the BLAST algorithm, which is described in Altschul et al., J. Mol. Biol. 215: 403-410 (1990). Software for performing BLAST analyses is publicly available through the National Center for Biotechnology Information (on the worldwide web at ncbi.nlm.nih.gov / ). This algorithm involves first identifying high scoring sequence pairs (HSPs) by identifying short words of length W in the query sequence that either match or satisfy some positive-valued threshold score T when aligned with a word of the same length in a database sequence. T is called the neighborhood word score threshold (Altschul et al., J. Mol. Biol. 215: 403-410 (1990)). These initial neighborhood word hits act as seeds for initiating searches to find longer HSPs containing them. The word hits are then extended in both directions along each sequence for as far as the cumulative alignment score can be increased. For nucleotide sequences, the cumulative score is calculated using the parameters M (reward score for a pair of matching residues; always > 0) and N (penalty score for mismatched residues; always < 0). For amino acid sequences, a scoring matrix is ​​used to calculate the cumulative score. Extension of the word hits in each direction is stopped when the cumulative alignment score has decreased by the amount X from its maximum achieved value; when the cumulative score approaches or falls below 0 due to the accumulation of one or more negative-scoring residue alignments; or when the end of either sequence is reached. The BLAST algorithm parameters W, T, and X determine the sensitivity and speed of the alignment.The BLASTN program (for nucleotide sequences) uses as defaults a word length (W) of 11, an expectation (E) of 10, a cutoff of 100, M=5, N=-4, and a comparison of both strands. For amino acid sequences, the BLASTP program uses as defaults a word length (W) of 3, an expectation (E) of 10, and the BLOSUM62 scoring matrix (see Henikoff & Henikoff, Proc. Natl. Acad. Sci. USA 89:10915 (1989)).

[0037] In addition to calculating percent sequence identity, the BLAST algorithm also performs a statistical analysis of the similarity between two sequences (see, e.g., Karlin and Altschul, Proc. Nat'l. Acad. Sci. USA 90:5873-5787 (1993)). One measure of similarity provided by the BLAST algorithm is the smallest sum probability (P(N)), which provides an indication of the probability that a match between two nucleotide or amino acid sequences would occur by chance. For example, a test nucleic acid sequence is considered similar to a reference sequence if the smallest sum probability in a comparison of the test nucleic acid sequence to the reference nucleic acid sequence is less than about 0.1, more preferably less than about 0.01, and most preferably less than about 0.001.

[0038] Another widely used and accepted computer program for performing sequence alignments is CLUSTALW v1.6 (Thompson, et al. Nuc. Acids Res., 22:4673-4680, 1994). The number of matched bases or amino acids is divided by the total number of bases or amino acids and multiplied by 100 to obtain the percent identity. For example, if two 580 base pair sequences have 145 matched bases, they would be 25% identical. If the two sequences being compared are of different lengths, the number of matches is divided by the shorter of the two lengths. For example, if there are 100 matched amino acids between a 200 amino acid protein and a 400 amino acid protein, the two proteins are 50% identical relative to the shorter sequence. If the shorter sequence is less than 150 bases or 50 amino acids in length, the number of matches is divided by 150 (for nucleic acid bases) or 50 (for amino acids) and multiplied by 100 to obtain the percent identity.

[0039] As used herein, two nucleic acids or proteins are considered substantially identical if the first protein is immunologically cross-reactive with the second protein. In addition, a first protein is generally considered to be substantially identical to a second protein, for example, where the two proteins differ only in conservative substitutions.

[0040] In many embodiments, the FatA acyl-ACP thioesterase should include at least a first amino acid substitution selected from the group consisting of: S76(G, A, L, M, F, W, K, Q, E, P, V, I, C, Y, H, R, N, D, T), L77(G, A, M, F, W, K, Q, E, S, P, V, I, C, Y, H, R, N, D, T), T78(G, A, L, M, F, W, K, Q, E, S, P, V, I, C, Y, H, R, N, D), D80(G, A, L, M, F, W, K, Q, E, S, P, V, I, C, Y, H, R, N, T), G81(A, L, M, F, W, K, Q, E, S, P, V, I, C, Y, H, R, N, D, T), L82(G, A, M, F, W, K, Q, E, S, P, V, I, C, Y, H, R, N, D, T), S83(G, A, L, M, F, W, K, Q, E, P, V, I, C, Y, H, R, N, D, T), Y84(G, A, L, M, F, W, K, Q, E, S, P, V, I, C, H, R, N, D, T), K85(G, A, L, M, F, W, Q, E, S, P, V, I, C, Y, H, R, N, D, T), E86(G, A, L, M, F, W, K, Q, S, P, V, I, C, Y, H, R, N, D, T), F88(G, A, L, M, W, K, Q, E, S, P, V, I, C, Y, H, R, N, D, T), I106(G, A, L, M, F, W, K, Q, E, S, P, V, C, Y, H, R, N, D, T), A107(G, L, M, F, W, K, Q, E, S, P, V, I, C, Y, H, R, N, D, T), N108(G, A, L, M, F, W, K, Q, E, S, P, V, I, C, Y, H, R, D, T), L109(G, A, M, F, W, K, Q, E, S, P, V, I, C, Y, H, R, N, D, T), L110(G, A, M, F, W, K, Q, E, S, P, V, I, C, Y, H, R, N, D, T), Q111(G, A, L, M, F, W, K, E, S, P, V, I, C, Y, H, R, N, D, T), E112(G, A, L, M, F, W, K, Q, S, P, V, I, C, Y, H, R, N, D, T), V113(G, A, L, M, F, W, K, Q, E, S, P, I, C, Y, H, R, N, D, T), G114(A, L, M, F, W, K, Q, E, S, P, V, I, C, Y, H, R, N, D, T), C115(G, A, L, M, F, W, K, Q, E, S, P, V, I, Y, H, R, N, D, T), N116(G, A, L, M, F, W, K, Q, E, S, P, V, I, C, Y, H, R, D,T)、H117(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、R、N、D、T)、A118(G、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、Q119(G、A、L、M、F、W、K、E、S、P、V、I、C、Y、H、R、N、D、T)、S120(G、A、L、M、F、W、K、Q、E、P、V、I、C、Y、H、R、N、D、T)、V121(G、A、L、M、F、W、K、Q、E、S、P、I、C、Y、H、R、N、D、T)、G122(A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、F123(G、A、L、M、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、S124(G、A、L、M、F、W、K、Q、E、P、V、I、C、Y、H、R、N、D、T)、T125(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D)、D126(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、T)、G127(A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、F128(G、A、L、M、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、A129(G、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、T130(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D)、T131(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D)、T132(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D)、T133(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D)、M134(G、A、L、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、R135(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、N、D、T)、L139(G、A、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、I140(G、A、L、M、F、W、K、Q、E、S、P、V、C、Y、H、R、N、D、T)、W141(G、A、L、M、F、K、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、V142(G、A、L、M、F、W、K、Q、E、S、P、I、C、Y、H、R、N、D、T)、T143(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D)、A144(G、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、R145(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、N、D、T)、M146(G、A、L、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、H147(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、R、N、D、T)、I162(G、A、L、M、F、W、K、Q、E、S、P、V、C、Y、H、R、N、D、T)、E163(G、A、L、M、F、W、K、Q、S、P、V、I、C、Y、H、R、N、D、T)、T164(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D)、W165(G、A、L、M、F、K、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、C166(G、A、L、M、F、W、K、Q、E、S、P、V、I、Y、H、R、N、D、T)、Q167(G、A、L、M、F、W、K、E、S、P、V、I、C、Y、H、R、N、D、T)、S168(G、A、L、M、F、W、K、Q、E、P、V、I、C、Y、H、R、N、D、T)、E169(G、A、L、M、F、W、K、Q、S、P、V、I、C、Y、H、R、N、D、T)、G170(A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、R171(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、N、D、T)、I172(G、A、L、M、F、W、K、Q、E、S、P、V、C、Y、H、R、N、D、T)、G173(A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、T174(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D)、R175(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、N、D、T)、R176(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、N、D、T)、D177(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、T)、W178(G、A、L、M、F、K、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、R191(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、N、D、T)、A192(G、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、T193(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D)、S194(G、A、L、M、F、W、K、Q、E、P、V、I、C、Y、H、R、N、D、T)、K195(G、A、L、M、F、W、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、W196(G、A、L、M、F、K、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、V197(G、A、L、M、F、W、K、Q、E、S、P、I、C、Y、H、R、N、D、T)、M198(G、A、L、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、M199(G、A、L、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、Q207(G、A、L、M、F、W、K、E、S、P、V、I、C、Y、H、R、N、D、T)、V209(G、A、L、M、F、W、K、Q、E、S、P、I、C、Y、H、R、N、D、T)、S210(G、A、L、M、F、W、K、Q、E、P、V、I、C、Y、H、R、N、D、T)、D212(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、T)、V213(G、A、L、M、F、W、K、Q、E、S、P、I、C、Y、H、R、N、D、T)、R214(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、N、D、T)、D215(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、T)、E216(G、A、L、M、F、W、K、Q、S、P、V、I、C、Y、H、R、N、D、T)、Y217(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、H、R、N、D、T)、L218(G、A、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、V219(G、A、L、M、F、W、K、Q、E、S、P、I、C、Y、H、R、N、D、T)、F220(G、A、L、M、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、C221(G、A、L、M、F、W、K、Q、E、S、P、V、I、Y、H、R、N、D、T)、P222(G、A、L、M、F、W、K、Q、E、S、V、I、C、Y、H、R、N、D、T)、Q223(G,A,L,M,F,W,K,E,S,P,V,I,C,Y,H,R,N,D,T), R226(G,A,L,M,F,W,K, Q, E, S, P, V, I, C, Y, H, N, D, T), D262 (G, A, L, M, F, W, K, Q, E, S, P, V, I, C, Y, H, R ,N,T),M263(G,A,L,F,W,K,Q,E,S,P,V,I,C,Y,H,R,N,D,T),N264(G,A,L,M, F, W, K, Q, E, S, P, V, I, C, Y, H, R, D, T), H266 (G, A, L, M, F, W, K, Q, E, S, P, V, I, C, C, Y, H, R, N, D, T), V267 (G, A, L, M, F, W, K, Q, E, S, P, I, C, Y, H, R, N, D, T), N268 (G, A, L, M, F, W, K, Q, E, S, P, V, I, C, Y, H, R, D, T), N269 (G, A, L, M, F, W, K, Q, E, S, P, V, I, C, Y, H, R, N, D, T), V270 (G, A, L, M, F, W, K, Q, E, S, P, I, C, Y, H, R, N, D, T), and Y297 (G, A, L, M, F, W, K, Q, E, S, P, V, I, C, H, R, N, D, T), wherein the position of the amino acid substitution is relative to that of SEQ ID NO: 1 The position of the amino acid sequence provided in SEQ ID NO: 1. For example, the S at position 76 of SEQ ID NO: 1 can be replaced by any of the following amino acids: G, A, L, M, F, W, K, Q, E, P, V, I, C, Y, H, R, N, D, or T.

[0041] In another embodiment, the FatA acyl-ACP thioesterase comprises at least a first amino acid substitution selected from the group consisting of R176A, R176C, R176V, Y217L, L218C, S168R, G114S, F123N, R191C, C221F, N269Y, F123C, S168C, F220H, V121N, N269W, A118V, and A144Y, wherein the position of the amino acid substitution is relative to the position of the amino acid sequence provided as SEQ ID NO:1. In another embodiment, the FatA acyl-ACP thioesterase comprises at least 2, at least 3, at least 4, at least 5, at least 6, or at least 7 of the amino acid substitutions R176A, R176C, R176V, Y217L, L218C, S168R, G114S, F123N, R191C, C221F, N269Y, F123C, S168C, F220H, V121N, N269W, A118V, and A144Y, wherein the position of the amino acid substitution is relative to the position of the amino acid sequence provided as SEQ ID NO:1. In another embodiment, the FatA acyl-ACP thioesterase comprises at least one pair of amino acid substitutions selected from the group consisting of R176A-R191C, R176C-R191C, and R176V-R191C, wherein the positions of the amino acid substitutions are relative to the position of the amino acid sequence provided as SEQ ID NO:1.

[0042] In some embodiments, the FatA acyl-ACP thioesterase is provided by editing an endogenous gene, e.g., as described in more detail below.

[0043] The FatA acyl-ACP thioesterase inhibiting herbicide may vary, but in many instances will be selected from the group consisting of compounds of formula (I):

[0044]

[0045] Where R 1 and R 2 Each independently is H, C 1 -C 6 Alkyl, C 1 -C 6 Haloalkyl, halogen or cyano, preferably Me, Cl, F or H. The following definitions apply to those terms used in the above formula (I):

[0046] C 1 -C 6 Alkyl and C 1 -C 4 The alkyl group includes, for example, methyl, ethyl, n-propyl, isopropyl and n-butyl.

[0047] Halogen encompasses fluorine, chlorine, bromine or iodine, preferably fluorine or chlorine.

[0048] C 1 -C 6 The haloalkyl group includes, for example, fluoromethyl, difluoromethyl, trifluoromethyl, chloromethyl, dichloromethyl, trichloromethyl, 2,2,2-trifluoroethyl, 2-fluoroethyl, 2-chloroethyl, pentafluoroethyl, 1,1-difluoro-2,2,2-trichloroethyl, 2,2,3,3-tetrafluoroethyl or 2,2,2-trichloroethyl; preferably trichloromethyl, difluorochloromethyl, difluoromethyl, trifluoromethyl or dichlorofluoromethyl.

[0049] It is to be understood that these compounds are chiral and therefore individual enantiomers and / or mixtures thereof are considered to be within the scope of the present invention.

[0050] Compounds of formula (I) and methods for their preparation are known from EP 0081893. Compounds of formula (I) (wherein R 1 =Me and R 2 =H) is more commonly known as cyproconazole. Another exemplary herbicide includes oxazithromycin.

[0051] It should be understood that in the above method, the herbicide composition can be applied to the site before crop emergence and / or after crop emergence (so-called "over-application". In a preferred embodiment, the herbicide composition is applied before crop emergence. A single or indeed multiple applications can be applied as required to obtain the desired weed control. The FatA acyl-ACP thioesterase inhibitory herbicide can be applied to the site at any suitable rate. Typically, the genome edited plants or transgenic plants of the present invention exhibit resistance or tolerance to FatA acyl-ACP thioesterase inhibiting herbicides applied in an amount of about 5 to about 2,000 grams of active ingredient per hectare (g / ha), including, for example, about 5 g / ha, about 10 g / ha, about 15 g / ha, about 20 g / ha, about 25 g / ha, about 30 g / ha, about 35 g / ha, about 40 g / ha, about 45 g / ha, about 50 g / ha, about 55 g / ha, about 60 g / ha, about 65 g / ha, about 70 g / ha, about 75 g / ha, about 80 g / ha, about 85 g / ha, about 86 g / ha, about 87 g / ha, about 88 g / ha, about 89 g / ha, about 90 g / ha, about 91 g / ha, about 92 g / ha, about 93 g / ha, about 94 g / ha, about 95 g / ha, about 96 g / ha, about 97 g / ha, about 98 g / ha, about 99 g / ha, about 100 g / ha, about 101 g / ha, about 102 g / ha, about 103 g / ha, about 104 g / ha, about 105 g / ha, about 106 g / ha g / ha, about 85 g / ha, about 90 g / ha, about 95 g / ha, about 100 g / ha, about 110 g / ha, about 120 g / ha, about 130 g / ha, about 140 g / ha, about 150 g / ha, about 160 g / ha, about 170 g / ha, about 180 g / ha, about 190 g / ha, about 200 g / ha, about 210 g / ha, about 220 g / ha, about 230 g / ha, about 240 g / ha, about 250 g / ha, about 260 g / ha, about 270 g / ha, about 280 g / ha, about 290 g / ha, about 300 g / ha g / ha, about 310 g / ha, about 320 g / ha, about 330 g / ha, about 340 g / ha, about 350 g / ha, about 360 g / ha, about 370 g / ha, about 380 g / ha, about 390 g / ha, about 400 g / ha, about 410 g / ha, about 420 g / ha, about 430 g / ha, about 440 g / ha, about 450 g / ha, about 460 g / ha, about 470 g / ha, about 480 g / ha, about 490 g / ha, about 500 g / ha, about 510 g / ha, about 520 g / ha, about 530 g / ha, about 540 g / ha 0g / ha, about 550g / ha, about 560g / ha, about 570g / ha, about 580g / ha, about 590g / ha, about 600g / ha, about 610g / ha, about 620g / ha, about 630g / ha, about 640g / ha, about 650g / ha, about 660g / ha, about 670g / ha, about 680g / ha, about 690g / ha, about 700g / ha, about 710g / ha, about 720g / ha, about 730g / ha, about 740g / ha, about 750g / ha, about 760g / ha, about 770g / ha,About 780g / ha, about 790g / ha, about 800g / ha, about 810g / ha, about 820g / ha, about 830g / ha, about 840g / ha, about 850g / ha, about 860g / ha, about 870g / ha, about 880g / ha, about 890g / ha, about 900g / ha, about 910g / ha, about 920g / ha, about 930g / ha, about 940g / ha, about 950g / ha, about 960g / ha, about 970g / ha, about 980g / ha, about 990g / ha, about 1,000g / ha, about 1,010g / ha, about 1,020g / ha, about 1,030g / ha, about 1,040g / ha, about 1,050g / ha, about 1,060g / ha, about 1,070g / ha, about 1,080g / ha, about 1,090g / ha, about 1,100g / ha, about 1,110g / ha, about 1,120g / ha, about 1,130g / ha, about 1,140g / ha, about 1,150g / ha, about 1,160g / ha, about 1,170g / ha, about 1,180g / ha, about 1,190g / ha, about 1,200g / ha, about 1,210g / ha, about 1,220g / ha, about 1,230g / ha, about 1,240g / ha, about 1,250g / ha, about 1,260g / ha, about 1,200g / ha, about 1,280g / ha, about 1,290g / ha, about 1,300g / ha, about 1,310g / ha, about 1,320g / ha, about 1,330g / ha, about 1,340g / ha, about 1,350g / ha, about 360g / ha, about 1,370g / ha, about 1,380g / ha, about 1,390g / ha, about 1,400g / ha, about 1,410g / ha, about 1,420g / ha, about 1,430g / ha, about 1,440g / ha, about 1,450g / ha, about 1,460g / ha, about 1,470g / ha, about 1,480g / ha, about 1,490g / ha, about 1, 1,500g / ha, about 1,510g / ha, about 1,520g / ha, about 1,530g / ha, about 1,540g / ha, about 1,550g / ha, about 1,560g / ha, about 1,570g / ha, about 1,580g / ha, about 1,590g / ha, about 1,600g / ha, about 1,610g / ha, about 1,620g / ha, about 1,630g / ha, about 1,640g / ha, about 1,650g / ha, about 1,660g / ha, about 1,670g / ha, about 1,680g / ha, about 1,690g / ha, about 1,700g / ha, about 1,710g / ha, about 1,720g / ha,about 1,730g / ha, about 1,740g / ha, about 1,750g / ha, about 1,760g / ha, about 1,770g / ha, about 1,780g / ha, about 1,790g / ha, about 1,800g / ha, about 1,810g / ha, about 1,820g / ha, about 1,830g / ha, about 1,840g / ha, about 1,850g / ha, about 1,860g / ha, about 1,870 g / ha, about 1,880 g / ha, about 1,890 g / ha, about 1,900 g / ha, about 1,910 g / ha, about 1,920 g / ha, about 1,930 g / ha, about 1,940 g / ha, about 1,950 g / ha, about 1,960 g / ha, about 1,970 g / ha, about 1,980 g / ha, about 1,990 g / ha, or about 2,000 g / ha.

[0052] The term "weeds" relates to any unwanted vegetation and includes, for example, stump or "rogue" or "volunteer" crop plants.

[0053] In addition, in many embodiments, the crop plant can contain a recombinant polynucleotide encoding an additional herbicide tolerance enzyme, wherein the additional herbicide tolerance enzyme is, for example, 5-enolpyruvylshikimate-3-phosphate synthase (EPSPS), glyphosate acetyltransferase (GAT), cytochrome P450, phosphinothricin acetyltransferase (PAT), acetolactate synthase (ALS), protoporphyrinogen oxidase (PPO), hydroxyphenylpyruvate dioxygenase (HPPD) or a dicamba degrading enzyme. Thus, the one or more additional herbicides may include glyphosate (including agrochemically acceptable salts thereof); glufosinate (including agrochemically acceptable salts thereof); chloroacetanilides, for example, alachlor, acetochlor, isopropyl metolachlor, S-isopropyl metolachlor; photosystem II inhibitors, for example, triazines such as ametryn, atrazine, cyanazine and terbuthylazine, triazinones such as hexazinone and metribuzin, and ureas such as chlorotoluron, diuron, isoproturon, linuron and butylthiocarb; ALS-inhibitors, for example, sulfonylureas such as acylosulfuron, chlorosulfuron, fluazifop-methyl, clopyrasulfuron, nicosulfuron, primisulfuron, prosulfuron, rimsulfuron, etherbensulfuron-methyl, trifloxysulfuron and trifloxysulfuron; diphenyl ethers, for example, acifluorfen and fomesafen; HPPD-inhibiting herbicides, such as mesotrione and flupyralidone; dicamba and 2,4D.

[0054] Recombinant polynucleotide

[0055] In other embodiments, the disclosure relates to recombinant polynucleotides. In one embodiment, the recombinant polynucleotide comprises a region encoding a FatA acyl-ACP thioesterase operably linked to a plant operable promoter. In one embodiment, the FatA acyl-ACP thioesterase is selected from the group consisting of: SEQ ID NO: 8-14, or SEQ ID NO: 20-23, or a DNA sequence encoding a FatA acyl-ACP thioesterase comprising at least a first amino acid substitution selected from the group consisting of S76 (G, A, L, M, F, W, K, Q, E, P, V, I, C, Y, H, R, N, D, T), L77 (G, A, M, F, W, K, Q, E, S, P, V, I, C, Y, H, R, N, D, T), T78 (G, A, L, M, F, W, K, Q, E, S, P, V, I, C, Y, H, R, N, D), D80 (G, A, L, M, F, W, K, Q, E, S, P, V, I ,C,Y,H,R,N,T),G81(A,L,M,F,W,K,Q,E,S,P,V,I,C,Y,H,R,N,D,T),L82(G,A,M,F,W,K,Q,E,S,P,V,I,C,Y,H,R,N,D,T),S83(G,A,L ,M,F,W,K,Q,E,P,V,I,C,Y,H,R,N,D,T),Y84(G,A,L,M,F,W,K,Q,E,S,P,V,I,C,H,R,N,D,T),K85(G,A,L,M,F,W,Q,E,S,P,V,I,C,Y, H, R, N, D, T), E86 (G, A, L, M, F, W, K, Q, S, P, V, I, C, Y, H, R, N, D, T), F88 (G, A, L, M, W, K, Q, E, S, P, V, I, C, Y, H, R, N, D, T), I106 (G, A, L, M ,F,W,K,Q,E,S,P,V,C,Y,H,R,N,D,T),A107(G,L,M,F,W,K,Q,E,S,P,V,I,C,Y,H,R,N,D,T),N108(G,A,L,M,F,W,K,Q,E,S,P,V,I,C, Y, H, R, D, T), L109 (G, A, M, F, W, K, Q, E, S, P, V, I, C, Y, H, R, N, D, T), L110 (G, A, M, F, W, K, Q, E, S, P, V, I, C, Y, H, R, N, D, T), Q111 (G, A, L ,M,F,W,K,E,S,P,V,I,C,Y,H,R,N,D,T),E112(G,A,L,M,F,W,K,Q,S,P,V,I,C,Y,H,R,N,D,T),V113(G,A,L,M,F,W,K,Q,E,S,P,I,C,Y、H、R、N、D、T)、G114(A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、C115(G、A、L、M、F、W、K、Q、E、S、P、V、I、Y、H、R、N、D、T)、N116(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、D、T)、H117(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、R、N、D、T)、A118(G、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、Q119(G、A、L、M、F、W、K、E、S、P、V、I、C、Y、H、R、N、D、T)、S120(G、A、L、M、F、W、K、Q、E、P、V、I、C、Y、H、R、N、D、T)、V121(G、A、L、M、F、W、K、Q、E、S、P、I、C、Y、H、R、N、D、T)、G122(A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、F123(G、A、L、M、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、S124(G、A、L、M、F、W、K、Q、E、P、V、I、C、Y、H、R、N、D、T)、T125(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D)、D126(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、T)、G127(A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、F128(G、A、L、M、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、A129(G、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、T130(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D)、T131(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D)、T132(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D)、T133(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D)、M134(G、A、L、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、R135(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、N、D、T)、L139(G、A、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、I140(G、A、L、M、F、W、K、Q、E、S、P、V、C、Y、H、R、N、D、T)、W141(G、A、L、M、F、K、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、V142(G、A、L、M、F、W、K、Q、E、S、P、I、C、Y、H、R、N、D、T)、T143(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D)、A144(G、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、R145(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、N、D、T)、M146(G、A、L、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、H147(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、R、N、D、T)、I162(G、A、L、M、F、W、K、Q、E、S、P、V、C、Y、H、R、N、D、T)、E163(G、A、L、M、F、W、K、Q、S、P、V、I、C、Y、H、R、N、D、T)、T164(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D)、W165(G、A、L、M、F、K、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、C166(G、A、L、M、F、W、K、Q、E、S、P、V、I、Y、H、R、N、D、T)、Q167(G、A、L、M、F、W、K、E、S、P、V、I、C、Y、H、R、N、D、T)、S168(G、A、L、M、F、W、K、Q、E、P、V、I、C、Y、H、R、N、D、T)、E169(G、A、L、M、F、W、K、Q、S、P、V、I、C、Y、H、R、N、D、T)、G170(A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、R171(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、N、D、T)、I172(G、A、L、M、F、W、K、Q、E、S、P、V、C、Y、H、R、N、D、T)、G173(A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、T174(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D)、R175(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、N、D、T)、R176(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、N、D、T)、D177(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、T)、W178(G、A、L、M、F、K、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、R191(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、N、D、T)、A192(G、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、T193(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D)、S194(G、A、L、M、F、W、K、Q、E、P、V、I、C、Y、H、R、N、D、T)、K195(G、A、L、M、F、W、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、W196(G、A、L、M、F、K、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、V197(G、A、L、M、F、W、K、Q、E、S、P、I、C、Y、H、R、N、D、T)、M198(G、A、L、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、M199(G、A、L、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、Q207(G、A、L、M、F、W、K、E、S、P、V、I、C、Y、H、R、N、D、T)、V209(G、A、L、M、F、W、K、Q、E、S、P、I、C、Y、H、R、N、D、T)、S210(G、A、L、M、F、W、K、Q、E、P、V、I、C、Y、H、R、N、D、T)、D212(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、T)、V213(G、A、L、M、F、W、K、Q、E、S、P、I、C、Y、H、R、N、D、T)、R214(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、N、D、T)、D215(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、T)、E216(G、A、L、M、F、W、K、Q、S、P、V、I、C、Y、H、R、N、D、T)、Y217(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、H、R、N、D、T)、L218(G、A、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、V219(G、A、L、M、F、W、K、Q、E、S、P、I、C、Y、H、R、N、D, T), F220 (G, A, L, M, W, K, Q, E, S, P, V, I, C, Y, H, R, N, D, T), C221 (G, A, L, M, F, W, K, Q, E, S, P, V, I, Y, H, R, N, D, T), P222 (G, A, L, M, F, W, K, Q, E, S, V, I, C, Y, H, R, N, D, T), Q223 (G, A, L, M, F, W, K, E, S, P ,V,I,C,Y,H,R,N,D,T),R226(G,A,L,M,F,W,K,Q,E,S,P,V,I,C,Y,H,N,D,T),D262(G,A,L,M,F,W, K, Q, E, S, P, V, I, C, Y, H, R, N, T), M263 (G, A, L, F, W, K, Q, E, S, P, V, I, C, Y, H, R, N, D, T), N264 (G, A, L ,M,F,W,K,Q,E,S,P,V,I,C,Y,H,R,D,T),H266(G,A,L,M,F,W,K,Q,E,S,P,V,I,C,Y,R,N,D,T),V2 67(G,A,L,M,F,W,K,Q,E,S,P,I,C,Y,H,R,N,D,T), N268(G,A,L,M,F,W,K,Q,E,S,P,V,I,C,Y,H,R, The amino acid substitutions are as follows: N269 (G, A, L, M, F, W, K, Q, E, S, P, V, I, C, Y, H, R, N, D, T), V270 (G, A, L, M, F, W, K, Q, E, S, P, I, C, Y, H, R, N, D, T), and Y297 (G, A, L, M, F, W, K, Q, E, S, P, V, I, C, H, R, N, D, T), wherein the positions of the amino acid substitutions are relative to those of SEQ ID NO:1; or a DNA sequence encoding a FatA acyl-ACP thioesterase comprising at least a first amino acid substitution selected from the group consisting of: R176A, R176C, R176V, Y217L, L218C, S168R, G114S, F123N, R191C, C221F, N269Y, F123C, S168C, F220H, V121N, N269W, A118V, and A144Y, wherein the position of the amino acid substitution is relative to the position of the amino acid sequence provided as SEQ ID NO:1.

[0056] In some embodiments of the recombinant polynucleotide, the FatA acyl-ACP thioesterase comprises at least 2, at least 3, at least 4, at least 5, at least 6, or at least 7 of the above-mentioned amino acid substitutions, such as at least 2, at least 3, at least 4, at least 5, at least 6, or at least 7 of R176A, R176C, R176V, Y217L, L218C, S168R, G114S, F123N, R191C, C221F, N269Y, F123C, S168C, F220H, V121N, N269W, A118V, and A144Y, wherein the position of the amino acid substitution is relative to the position of the amino acid sequence provided as SEQ ID NO: 1. In another embodiment, the FatA acyl-ACP thioesterase comprises an amino acid substitution selected from the group consisting of R176A-R191C, R176C-R191C, and R176V-R191C, wherein the position of the amino acid substitution is relative to the position of the amino acid sequence provided as SEQ ID NO:1.

[0057] Embodiments of the recombinant polynucleotide may further include at least one additional region operably linked to a plant operable promoter, the region encoding a herbicide tolerance enzyme selected from the group consisting of: hydroxyphenylpyruvate dioxygenase (HPPD), 5-enolpyruvylshikimate-3-phosphate synthase (EPSPS), glyphosate acetyltransferase (GAT), cytochrome P450, phosphinothricin acetyltransferase (PAT), acetolactate synthase (ALS), protoporphyrinogen oxidase (PPO), hydroxyphenylpyruvate dioxygenase (HPPD) and dicamba degrading enzyme.

[0058] Typically, the recombinant polynucleotide will comprise (i) a plant operable promoter and (iii) a transcription terminator operably linked to (ii) a region encoding a FatA acyl-ACP thioesterase. Typically, the recombinant polynucleotide will further comprise a region encoding a polypeptide that can target the FatA acyl-ACP thioesterase to a subcellular organelle such as a chloroplast. The recombinant polynucleotide may further comprise, for example, a transcription enhancer. In addition, the region encoding the FatA acyl-ACP thioesterase may be "codon optimized" depending on the plant host in which the FatA acyl-ACP thioesterase needs to be expressed. The skilled person is well aware of plant operable promoters, transcription terminators, chloroplast transit peptides, enhancers, etc. that are useful in the context of the present invention.

[0059] The FatA acyl-ACP thioesterase may be a "native" or "wild-type" enzyme or it may be an enzyme that has been modified to provide preferential kinetic properties (with respect to providing herbicide-tolerant plants).

[0060] Suitable FatA acyl-ACP thioesterases are derived, for example, from Arabidopsis thaliana, common wheat, barley, rice, maize, and soybean. In one embodiment, the FatA acyl-ACP thioesterase is selected from the group consisting of SEQ ID NO: 1 to SEQ ID NO. 7. It should be noted that the amino acid sequences provided in SEQ ID NO: 1 to 7 are examples of FatA acyl-ACP thioesterase amino acid sequences that include a region encoding a chloroplast transit peptide.

[0061] SEQ ID NOs 8-14 correspond to DNA sequences encoding FatA acyl-ACP thioesterase, described as SEQ ID NOs. 1-7, respectively.

[0062] SEQ ID No. 15 depicts the "mature" His-tagged Arabidopsis thaliana FatA acyl-ACP thioesterase.

[0063] Method of producing plants

[0064] The present disclosure also relates to various methods for producing plants tolerant to FatA inhibitory herbicides. For example, the recombinant polynucleotides of the present invention can be introduced into the genome of the desired plant host by various conventional transformation techniques known to those skilled in the art. "Transformation" refers to the introduction of exogenous polynucleic acid molecules (e.g., recombinant polynucleotides) into cells or protoplasts, and the exogenous polynucleic acid molecules are incorporated into the host cell genome or organelle genome (e.g., chloroplasts or mitochondria) or are capable of autonomous replication. "Transformed" or "transgenic" refers to cells, tissues, organs or organisms into which foreign polynucleic acids, such as DNA vectors or recombinant polynucleotides, have entered. "Transgenic" or "transformed" cells or organisms also include progeny of the cells or organisms and progeny produced from a breeding program, wherein the breeding program uses the "transgenic" plants as parents in hybridization, and the progeny produced from the breeding program exhibit altered phenotypes due to the presence of foreign polynucleic acid molecules.

[0065] Methods for transformation of plant cells or tissues include, but are not limited to, Agrobacterium-mediated transformation methods and biolistic or particle gun-mediated transformation methods. Suitable plant transformation vectors for the purpose of Agrobacterium-mediated transformation include those elements derived from the tumor-inducing (Ti) plasmid of Agrobacterium tumefaciens, such as the right border (RB) region and the left border (LB) region, and other elements disclosed by Herrera-Estrella et al., Nature 303:209 (1983); Bevan, Nucleic Acids Res. 12:8711-8721 (1984); Klee et al., Bio-Technology 3(7):637-642 (1985). In addition to plant transformation vectors derived from the Agrobacterium Ti or root-inducing (Ri) plasmid, alternative methods may be used to insert the DNA constructs of the present invention into plant cells. These methods may involve, but are not limited to, for example, the use of liposomes, electroporation, chemicals that increase free DNA uptake, free DNA delivery by microprojectile bombardment, and transformation using viruses or pollen.

[0066] DNA constructs incorporating the FatA acyl-ACP thioesterase coding sequences of the invention can be prepared for directing expression of the sequences directly from a host plant cell plasmid. Examples and methods of such constructs suitable for this purpose are known in the art and are generally described in, for example, Svab et al., Proc. Natl. Acad. Sci. USA [Proceedings of the National Academy of Sciences of the United States] 87: 8526-8530, (1990) and Svab et al., Proc. Natl. Acad. Sci. USA [Proceedings of the National Academy of Sciences of the United States] 90: 913-917 (1993) and U.S. Pat. No. 5,693,507.

[0067] When a sufficient number of cells containing exogenous polynucleic acid molecules encoding polypeptides of the present invention are obtained, the cells can be cultured and then regenerated into whole plants. "Regeneration" refers to the process of growing a plant from a plant cell (e.g., a plant protoplast or explant). This regeneration technique relies on the manipulation of certain plant hormones in the tissue culture growth medium, typically relying on biocides and / or herbicide markers that have been introduced with the desired nucleotide sequence. The choice of methodology for the regeneration step is not critical, see, e.g., Ammirato et al., Handbook of Plant Cell Culture—Crop Species. Macmillan Publ. Co. (1984); Shimamoto et al., Nature 338:274-276 (1989); Fromm, UCLA Symposium on Molecular Strategies for Crop Improvement, April 16-22, 1990. Keystone, Colo. (1990); Vasil et al., Bio / Technology 8:429-434 (1990); Vasil et al., Bio / Technology 10:667-674 (1992); Hayashimoto, Plant Cell Culture 10:667-674 (1992); Physiol. 93:857-863 (1990); and Datta et al., Bio-technology 8:736-740 (1990). Such regeneration techniques are generally described in Klee et al., Ann. Rev. Plant Phys. 38:467-486 (1987).

[0068] The growth or regeneration of transgenic plants containing the exogenous polynucleic acid molecules encoding the polypeptide of interest is well known in the art. The regenerated plants can be self-pollinated to provide homozygous transgenic plants, as described above. In addition, the pollen obtained from the regenerated plants is hybridized with the seed-grown plants of important agronomic lines. On the contrary, the pollen from these important lines of plants is used to pollinate the regenerated plants.

[0069] The present invention further provides a method for providing transgenic plants tolerant to FatA acyl-ACP thioesterase-inhibiting herbicides, the method comprising transforming plant material with one or more recombinant polynucleotides comprising a region encoding a FatA acyl-ACP thioesterase, selecting the transformed plant material using a FatA acyl-ACP thioesterase-inhibiting herbicide and regenerating the material into morphologically normal fertile plants.

[0070] Figure 1 An example of a binary vector suitable for introducing the recombinant polynucleotides disclosed herein into crop plants is exemplified. As described, the vectors herein are shown in plasmid form, but in other examples, the expression cassette can be isolated DNA or can be a feature in a viral vector. In this example, the vector was constructed to introduce Arabidopsis FatA acyl-ACP thioesterase with the R176A mutation into plants. Figure 1 The vector has the following characteristics: FatA acyl-ACP thioesterase AraFatA1R176A (start: 826, end: 1914); neomycin phosphotransferase coding sequence cNpt2-10 (start: 2522, end: 3316); replication trfA gene cTrfA-01 (start: 6338, end: 7486); aminoglycoside 3'-phosphotransferase cNpt3-01-02 (start: 7785, end: 8579); gene encoding relaxosome protein TraJ cTraJ-01 (start: 10999, end: 11370); tetracycline resistance repressor gene cTETR-01-01 (start: 12193, end: 12843); eTMV (start: 756, end: 825); left border region bNLB-03 of the T-DNA of the nopaline ti plasmid of Agrobacterium tumefaciens (start: 4683, end: 4812); 25 bp left border region bNLB-01-01 of the T-DNA of the nopaline ti plasmid of Agrobacterium tumefaciens (start: 4718 end: 4742); right border region bNRB-03 of the T-DNA of the nopaline ti plasmid of Agrobacterium tumefaciens (start: 13211, end: 13376); right border repeat bNRB-01-01 of the T-DNA of the nopaline ti plasmid of Agrobacterium tumefaciens (start: 13308, end: 13332); promoter pNOS_R (start: 2214; end: 2240); promoter prNOS-01-01 (start: 2203, end: 2509); promoter pr35S-07-01 (start: 4, end: 330); promoter pr35S-10-01 (start: 331, end: 747); promoter prNpt3-01 (start: 9539, end: 9890); origin of replication oriV oRK2-01 (start: 10237, end: 10854); origin of transfer oOriT-01 (start: 11403, end: 11514); oCOLE-03-01 (start: 11644, end: 11959); terminator tNOS-05-01 (start: 1937, end: 2189); terminator tNOS-05-01 (start: 3706, end: 3958).

[0071] One of ordinary skill in the art can construct and employ any number of vector designs to practice the various embodiments of the present disclosure.

[0072] According to the present disclosure, plants with tolerance to FatA inhibitory herbicides can also be produced in other ways. In some embodiments, endogenous FatA acyl-ACP thioesterase is edited in situ by gene editing technology to provide FatA acyl-ACP thioesterase with tolerance to FatA acyl-ACP thioesterase inhibitory herbicides. Such genome editing and / or mutagenesis techniques are well known in the art. Similarly, introduction can be completed by any means known in the art, including: gene introgression, transgenic or site-directed nuclease (SDN). In particular, modification of the nucleic acid sequence is introduced by means of a site-directed nuclease (SDN). More particularly, SDN is selected from: a large range of nucleases, zinc fingers, a transcription activator-like effector nuclease system (TALEN) or a clustered regularly spaced short palindromic repeat system (CRISPR). SDN is also referred to as "genome editing", or genome editing (GEEN) with engineered nucleases. This is a type of genetic engineering, in which an engineered nuclease that produces a site-specific double-strand break (DSB) at a desired location in the genome is used to insert, delete or replace DNA in the genome of an organism. The induced double-strand breaks are repaired by non-homologous end joining (NHEJ) or homologous recombination (HR), resulting in targeted mutations ('editing'). In particular, SDN can include the following technologies, such as: large-range nucleases, zinc finger nucleases (ZFNs), transcription activator-like effector nucleases (TALENs) (Feng et al. 2013 Cell Res. [Cell Research] 23, 1229-1232, Sander and Joung Nat. Biotechnol. [Natural Biotechnology] 32, 347-355 2014), and clustered regularly spaced short palindromic repeats (CRISPR-Cas) systems. Gene editing can also be achieved by SDN-2. SDN-2 is similar to SDN, but also provides a small nucleotide template complementary to the break region. The template contains one or more sequence modifications to the genomic DNA that are incorporated to generate mutations to the target gene.

[0073] For example, in one embodiment, the present disclosure relates to a method for producing a plant that is tolerant to a FatA acyl-ACP thioesterase-inhibiting herbicide by: a) transforming a recombinant polynucleotide into a plant cell or plant tissue, wherein the recombinant polynucleotide comprises a nucleic acid encoding a DNA modification enzyme, and a nucleic acid encoding at least one guide RNA (gRNA), wherein the at least one guide RNA mediates at least one modification of a FatA acyl-ACP thioesterase; and b) regenerating the plant cell or plant tissue into a TO plant having a T1 seed, wherein the T1 seed can be regenerated to produce an edited plant that is tolerant to a FatA acyl-ACP thioesterase-inhibiting herbicide.

[0074] The at least one gRNA can mediate at least a first amino acid substitution selected from the group consisting of: S76 (G, A, L, M, F, W, K, Q, E, P, V, I, C, Y, H, R, N, D, T), L77 (G, A, M, F, W, K, Q, E, S, P, V, I, C, Y, H, R, N, D, T), T78 (G, A, L, M, F, W, K, Q, E, S, P, V, I, C, Y, H, R, N, D), D80 (G, A, L, M, F, W, K, Q, E, S, P, V, I, C, Y, H, R, N, T), G81 (A, L, M, F, W, K, Q, E, S, P, V, I, C, Y, H, R, N, D, T), L82 (G, A, M, F, W, K, Q, E, S, P, V, I, C, Y, H, R, N, D, T), S83 (G, A, L, M, F, W, K, Q, E, P, V, I, C, Y, H, R, N, D, T), Y84 (G, A, L, M, F, W, K, Q, E, S, P, V, I, C, H, R, N, D, T), K85 (G, A, L, M, F, W, Q, E, S, P, V, I, C, Y, H, R, N, D, T), E86 (G, A, L, M, F, W, K, Q, S, P, V, I, C, Y, H, R, N, D, T), F88 (G, A, L, M, W, K, Q, E, S, P, V, I, C, Y, H, R, N, D, T), I106 (G, A, L, M, F, W, K, Q, E, S, P, V, C, Y, H, R, N, D, T), A107 (G, L, M, F, W, K, Q, E, S, P, V, I, C, Y, H, R, N, D, T), N108 (G, A, L, M, F, W, K, Q, E, S, P, V, I, C, Y, H, R, D, T), L109 (G, A, M, F, W, K, Q, E, S, P, V, I, C, Y, H, R, N, D, T), L110 (G, A, M, F, W, K, Q, E, S, P, V, I, C, Y, H, R, N, D, T), Q111 (G, A, L, M, F, W, K, E, S, P, V, I, C, Y, H, R, N, D, T), E112 (G, A, L, M, F, W, K, Q, S, P, V, I, C, Y, H, R, N, D, T), V113 (G, A, L, M, F, W, K, Q, E, S, P, I, C, Y, H, R, N, D, T), G114 (A, L, M, F, W, K, Q, E, S, P, V, I, C, Y, H, R, N, D, T), C115 (G, A, L, M, F, W, K, Q, E, S, P, V, I, Y, H, R, N, D, T), N116 (G, A, L, M, F, W, K, Q, E, S, P, V, I, C, Y, H, R, D, T), H117 (G,A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、R、N、D、T)、A118(G、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、Q119(G、A、L、M、F、W、K、E、S、P、V、I、C、Y、H、R、N、D、T)、S120(G、A、L、M、F、W、K、Q、E、P、V、I、C、Y、H、R、N、D、T)、V121(G、A、L、M、F、W、K、Q、E、S、P、I、C、Y、H、R、N、D、T)、G122(A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、F123(G、A、L、M、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、S124(G、A、L、M、F、W、K、Q、E、P、V、I、C、Y、H、R、N、D、T)、T125(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D)、D126(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、T)、G127(A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、F128(G、A、L、M、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、A129(G、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、T130(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D)、T131(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D)、T132(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D)、T133(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D)、M134(G、A、L、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、R135(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、N、D、T)、L139(G、A、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、I140(G、A、L、M、F、W、K、Q、E、S、P、V、C、Y、H、R、N、D、T)、W141(G、A、L、M、F、K、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、V142(G、A、L、M、F、W、K、Q、E、S、P、I、C、Y、H、R、N、D、T)、T143(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D)、A144(G、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、R145(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、N、D、T)、M146(G、A、L、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、H147(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、R、N、D、T)、I162(G、A、L、M、F、W、K、Q、E、S、P、V、C、Y、H、R、N、D、T)、E163(G、A、L、M、F、W、K、Q、S、P、V、I、C、Y、H、R、N、D、T)、T164(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D)、W165(G、A、L、M、F、K、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、C166(G、A、L、M、F、W、K、Q、E、S、P、V、I、Y、H、R、N、D、T)、Q167(G、A、L、M、F、W、K、E、S、P、V、I、C、Y、H、R、N、D、T)、S168(G、A、L、M、F、W、K、Q、E、P、V、I、C、Y、H、R、N、D、T)、E169(G、A、L、M、F、W、K、Q、S、P、V、I、C、Y、H、R、N、D、T)、G170(A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、R171(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、N、D、T)、I172(G、A、L、M、F、W、K、Q、E、S、P、V、C、Y、H、R、N、D、T)、G173(A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、T174(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D)、R175(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、N、D、T)、R176(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、N、D、T)、D177(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、T)、W178(G、A、L、M、F、K、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、R191(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、N、D、T)、A192(G、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、T193(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D)、S194(G、A、L、M、F、W、K、Q、E、P、V、I、C、Y、H、R、N、D、T)、K195(G、A、L、M、F、W、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、W196(G、A、L、M、F、K、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、V197(G、A、L、M、F、W、K、Q、E、S、P、I、C、Y、H、R、N、D、T)、M198(G、A、L、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、M199(G、A、L、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、Q207(G、A、L、M、F、W、K、E、S、P、V、I、C、Y、H、R、N、D、T)、V209(G、A、L、M、F、W、K、Q、E、S、P、I、C、Y、H、R、N、D、T)、S210(G、A、L、M、F、W、K、Q、E、P、V、I、C、Y、H、R、N、D、T)、D212(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、T)、V213(G、A、L、M、F、W、K、Q、E、S、P、I、C、Y、H、R、N、D、T)、R214(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、N、D、T)、D215(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、T)、E216(G、A、L、M、F、W、K、Q、S、P、V、I、C、Y、H、R、N、D、T)、Y217(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、H、R、N、D、T)、L218(G、A、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、V219(G、A、L、M、F、W、K、Q、E、S、P、I、C、Y、H、R、N、D、T)、F220(G、A、L、M、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、C221(G、A、L、M、F、W、K、Q、E、S、P、V、I、Y、H、R、N、D、T)、P222(G、A、L、M、F、W、K、Q、E、S、V、I、C、Y、H、R、N、D、T)、Q223(G、A、L、M、F、W, K, E, S, P, V, I, C, Y, H, R, N, D, T), R226 (G, A, L, M, F, W, K, Q, E, S, P, V, I, C ,Y,H,N,D,T),D262(G,A,L,M,F,W,K,Q,E,S,P,V,I,C,Y,H,R,N,T),M263(G ,A,L,F,W,K,Q,E,S,P,V,I,C,Y,H,R,N,D,T),N264(G,A,L,M,F,W,K,Q,E, S, P, V, I, C, Y, H, R, D, T), H266 (G, A, L, M, F, W, K, Q, E, S, P, V, I, C, Y, R, N, D, C, Y, H, R, N, D, T), V270 (G, A, L, M, F, W, K, Q, E, S, P, I, C, Y, H, R, N, D, T), and Y297 (G, A, L, M, F, W, K, Q, E, S, P, V, I, C, Y, H, R, N, D, T), wherein the position of the amino acid substitution is relative to the position of the amino acid sequence provided as SEQ ID NO:1. In other embodiments, at least one gRNA can mediate at least 2, at least 3, at least 4, at least 5, at least 6, or at least 7 of these amino acid substitutions. In another embodiment of the method, at least one gRNA mediates at least a first amino acid substitution selected from the group consisting of R176A, R176C, R176V, Y217L, L218C, S168R, G114S, F123N, R191C, C221F, N269Y, F123C, S168C, F220H, V121N, N269W, A118V, and A144Y, wherein the position of the amino acid substitution is relative to the position of the amino acid sequence provided as SEQ ID NO: 1. In another embodiment of the method, at least one gRNA mediates an amino acid substitution selected from the group consisting of R176A-R191C, R176C-R191C, and R176V-R191C.

[0075] Figure 2Examples of binary vectors (SEQ ID NO: 25) suitable for in situ editing of natural maize FatA acyl-ACP thioesterase are illustrated. As described, the expression cassette features herein are shown as plasmid forms, but in other examples, the expression cassette can be isolated DNA or can be a feature in a viral vector. In short, the expression cassette can include nucleic acids encoding DNA modification enzymes and nucleic acids encoding at least one guide RNA (gRNA). A variety of DNA modification enzymes can be used, such as meganucleases (MNs), zinc finger nucleases (ZFNs), transcription activator-like effector nucleases (TALENs), Cas9 nucleases, Cfp1 nucleases, dCas9-FokI, dCpf1-FokI, chimeric Cas9-cytidine deaminases, chimeric Cas9-adenine deaminases, chimeric FEN1-FokI and Mega-TALs, nickase Cas9 (nCas9), chimeric dCas9 non-FokI nucleases and dCpf1 non-FokI nucleases. According to the nuclease used, at least one gRNA is optionally included. For example, when a nuclease (such as Cas or Cpf) forming a nuclease-gRNA complex is used, it is desirable to use at least one nucleic acid encoding gRNA. Further, gRNA can be single-stranded, or more than one chain can be included, for example, a target agent-RNA (targeter-RNA) hybridized with a target DNA sequence and an activator-RNA (activator-RNA) hybridized with a target agent-RNA. U.S. Patent No. 8,697,359 and U.S. Patent No. 10,000,772 and U.S. Patent Publication US 20160208243 describe various single and multiple guide RNA methods. In addition, for other examples, such as SDN-2, a template DNA having a desired modification incorporated therein can be included.

[0076] The expression cassette may include additional features. For example, a gRNA promoter regulates the expression of at least one gRNA, such as prOsU3-01, which is a rice U3 promoter for pol III-dependent transcription of non-coding RNA. The vector may similarly include additional features such as, a selectable marker, such as phosphomannose isomerase (PMI) and can be used with mannose selection to recover stably transformed plants. Additional features include regulatory sequences, such as promoters and terminators for regulating the expression of selectable markers. Referring now to Figure 2vector, the features including the following RNA-guided endonucleases: Class II CRISPR / Cas system cLbCpf1-02 (start: 2049, end: 5831); phosphomannose isomerase gene cPMI-09 (start: 10334, end: 11512); spectinomycin and streptomycin resistance gene cSpec-03 (start: 12240, end: 13028); cVirG-09 (start: 13328, end: 13960); replication protein cRepA-01 (start: 13990 end: 15063); right border region bNRB-04 of the T-DNA inserted into the Agrobacterium tumefaciens ti-plasmid (start: 4, end: 143); right border repeat bNRB-01-01 (start: 101, end: 125); left border region bNLB-03 of the T-DNA of the Agrobacterium tumefaciens nopaline ti plasmid (start: 11831, end: 11960); promoter prSoUbi4-02 (start: 229, end: 2030); promoter prSoUbi4-02 (start: 6099, end: 7900); promoter prUbi1-04 (start: 8326, end: 10317); origin of replication oVS1-02 (start: 15106, end: 15510); origin of replication oCOLE-06 (start: 16188, end: 16994); terminator tNOS-05-01 (start: 5840, end: 6092); terminator tNOS-05-01 (start: 8063, end: 8315); terminator tNOS-05-01 (start: 11535, end: 11787); conserved sequence motif rHH-01 of the satellite RNA responsible for self-cleavage from certain viruses (including Tobacco ringspot virus) (start: 7908, end: 7950); scaffold crRNA of LbCpf1, also known as direct repeat (DR) rLbCrRNA-01 of the guide RNA (start: 7951, end: 7971); CRISPR / Cpf1 guide RNA, which includes the direct repeat rLbgRNACpf1ZmLHT1-01 of the Lachnospiraceae bacterium ND2006LbCrRNA (target sequence ctgacggacgcgccccacgcgat) (start: 7951, end: 7971); sequence rHDV-01 encoding a self-cleaving ribozyme (start: 7995, end: 8062); ZmFatA (start: 7972, end: 7994).

[0077] In another embodiment, the present disclosure relates to a recombinant polynucleotide comprising: a nucleic acid encoding a DNA modification enzyme; and a nucleic acid encoding at least one guide RNA (gRNA), wherein the at least one guide RNA mediates at least one modification to a FatA acyl-ACP thioesterase, as described in the above method.

[0078] It should be further understood that the crop plants used in the above-described methods may further comprise additional recombinant polynucleotides encoding additional herbicide tolerant enzymes. Examples of additional herbicide tolerant enzymes include, for example, herbicide tolerant enzymes selected from the group consisting of: 5-enolpyruvylshikimate-3-phosphate synthase (EPSPS), glyphosate acetyltransferase (GAT), cytochrome P450, phosphinothricin acetyltransferase (PAT), acetolactate synthase (ALS), protoporphyrinogen oxidase (PPO), hydroxyphenylpyruvate dioxygenase (HPPD), phytoene dehydrogenase (PD), dicamba degrading enzyme (e.g., WO02 / 068607) and aryloxy herbicide degrading enzyme (as taught in WO 2007 / 053482 and WO 2005 / 107437).

[0079] The pesticide composition may further comprise one or more additional pesticidal ingredients. Additional pesticidal ingredients may include, for example, herbicides (as discussed), but may also include fungicides and / or insecticides. Preferably, the pesticide composition used in the above method may further comprise one or more additional herbicides to which the crop plants are naturally tolerant, or to which the crop plants are rendered resistant via expression of one or more additional transgenes as mentioned herein. In a preferred embodiment, one or more additional herbicides are selected from the group consisting of: glyphosate (including its agrochemically acceptable salts); glufosinate (including its agrochemically acceptable salts); chloroacetanilides, for example, metolachlor, acetochlor, isopropyl metolachlor, S-isopropyl metolachlor; photosystem II inhibitors, for example, triazines (such as amethoxam, atrazine, cyanazine and terbuthylazine), triazinones (such as cyclazine and metribuzin), ureas (such as chlorotoluron, diuron, isoproturon, limidazole); ALS-inhibitors, for example, sulfonylureas, such as amidosulfuron, chlorsulfuron, fluazifop-methyl, clopyrasulfuron, nicosulfuron, primisulfuron, prosulfuron, rimsulfuron, bensulfuron-methyl, trifloxysulfuron and trifloxysulfuron; diphenyl ethers, for example, acifluorfen and fomesafen; HPPD-inhibiting herbicides, such as mesotrione and flupyralidone; dicamba (including agrochemically acceptable salts thereof) and 2,4D (including agrochemically acceptable salts thereof).

[0080] The present invention further provides a recombinant polynucleotide comprising (i) a region encoding a FatA acyl-ACP thioesterase operably linked to a plant operable promoter and (ii) at least one additional heterologous polynucleotide comprising a region encoding an additional herbicide tolerant enzyme operably linked to a plant operable promoter. The additional herbicide tolerant enzyme is, for example, selected from the group consisting of hydroxyphenylpyruvate dioxygenase (HPPD), 5-enolpyruvylshikimate-3-phosphate synthase (EPSPS), glyphosate acetyltransferase (GAT), cytochrome P450, phosphinothricin acetyltransferase (PAT), acetolactate synthase (ALS), protoporphyrinogen oxidase (PPO), phytoene dehydrogenase (PD), and dicamba degrading enzyme (as taught in WO 02 / 068607).

[0081] In some embodiments, the recombinant polynucleotide comprises (i) a region encoding a FatA acyl-ACP thioesterase operably linked to a plant operable promoter and (ii) a region encoding an HPPD operably linked to a plant operable promoter. The recombinant polynucleotide may also comprise at least two, three or more additional regions, each region encoding, for example, a herbicide tolerance enzyme as previously defined. Thus, in another embodiment, the recombinant polynucleotide comprises (i) a region encoding a FatA acyl-ACP thioesterase, (ii) a region encoding an HPPD enzyme and (iii) a region encoding a glyphosate tolerance enzyme.

[0082] The present invention further provides a vector comprising the recombinant polynucleotide according to the present invention.

[0083] Plant Cells

[0084] A "plant cell" is a structural and physiological unit of a plant, comprising a protoplast and a cell wall. A plant cell may be in the form of an isolated single cell or a cultured cell, or as part of a higher organizational unit such as, for example, a plant tissue, a plant organ, or a whole plant. A "plant organ" is a distinct and distinct structured and differentiated part of a plant, such as a root, stem, leaf, flower bud, or embryo.

[0085] As used herein, the term "plant part" includes, but is not limited to, embryos, pollen, ovules, seeds, leaves, flowers, branches, fruits, stems, roots, root tips, anthers, and / or plant cells (including intact plant cells in plants and / or parts of plants), plant protoplasts, plant tissues, plant cell tissue cultures, plant calli, plant clumps, etc. "Plant tissue" as used herein means a group of plant cells organized into structural and functional units. Any plant tissue in a plant or in culture is included. This term includes, but is not limited to: whole plants, plant organs, plant seeds, tissue cultures, and any group of plant cells organized into structural or functional units. The combined use or separate use of this term with any specific type of plant tissue listed above or otherwise covered by this definition is not intended to exclude any other type of plant tissue.

[0086] Therefore, the present invention further relates to transformed plants that overexpress a FatA acyl-ACP thioesterase, which transformed plants exhibit significant resistance or significant tolerance to FatA acyl-ACP thioesterase inhibiting herbicides compared to similar untransformed plants.

[0087] In some embodiments, plant cells may comprise recombinant polynucleotides as described herein. It should be understood that the region encoding the FatA acyl-ACP thioesterase and any region encoding one or more additional herbicide tolerance enzymes can be provided on the same ("connected") or actually separate transforming recombinant polynucleotide molecules. In some embodiments, plant cells will be produced using gene editing techniques as described herein.

[0088] The plant cells may further comprise additional transgenic traits, such as a heterologous polynucleotide that provides resistance to insects, fungi and / or nematodes.

[0089] The present invention further provides morphologically normal fertile FatA acyl-ACP thioesterase inhibitor tolerant plants, plant cells, tissues and seeds comprising the plant cells according to the present invention.

[0090] Transformed or edited plants or plant cells include, but are not limited to, field crops, fruits and vegetables, such as canola, sunflower, tobacco, beet, cotton, maize, common wheat, barley, rice, sorghum, tomato, mango, peach, apple, pear, strawberry, banana, melon, mangelworzel, potato, carrot, lettuce, cabbage, onion, etc. Particularly preferred transgenic plants are soybean, sugarcane, pea, broad bean, poplar, grape, citrus, alfalfa, rye, oat, lawn grass and forage grass, flax and rapeseed, and nut production plants not yet specifically mentioned. In a particularly preferred embodiment of the method, the plant is a dicotyledonous plant, preferably selected from the group consisting of canola, sunflower, tobacco, beet, soybean, cotton, sorghum, tomato, mango, peach, apple, pear, strawberry, banana, melon, potato, carrot, lettuce, cabbage, onion, and particularly preferably soybean. In another preferred embodiment, the plant is maize or rice. Preferably, the plant of the present invention is soybean, rice or maize. The present invention also includes the offspring of the aforementioned plants, and the seeds or other propagation materials of such plants and offspring.

[0091] In one embodiment, the plant cell comprises a recombinant polynucleotide as described herein, or a DNA sequence encoding a FatA acyl-ACP thioesterase comprising at least a first amino acid substitution selected from the group consisting of S76 (G, A, L, M, F, W, K, Q, E, P, V, I, C, Y, H, R, N, D, T), L77 (G, A, M, F, W, K, Q, E, S, P, V, I, C, Y, H, R, N, D, T), T78 (G, A, L, M, F, W, K, Q, E, S, P, V, I, C, Y, H, R, N, D), D80 (G, A, L, M, F, W, K, Q, E, S, P, V, I, C, Y, H, R, N, D), G81 (A, L, M, F, W, K, Q, E, S, P, V, I, C, Y, H, R, N, D, T), L82 (G, A, M, F, W, K, Q, E ,S,P,V,I,C,Y,H,R,N,D,T),S83(G,A,L,M,F,W,K,Q,E,P,V,I,C,Y,H,R,N,D ,T),Y84(G,A,L,M,F,W,K,Q,E,S,P,V,I,C,H,R,N,D,T),K85(G,A,L,M,F,W ,Q,E,S,P,V,I,C,Y,H,R,N,D,T),E86(G,A,L,M,F,W,K,Q,S,P,V,I,C,Y,H,R ,N,D,T),F88(G,A,L,M,W,K,Q,E,S,P,V,I,C,Y,H,R,N,D,T),I106(G,A,L, M, F, W, K, Q, E, S, P, V, C, Y, H, R, N, D, T), A107 (G, L, M, F, W, K, Q, E, S, P, V, I, C ,Y,H,R,N,D,T),N108(G,A,L,M,F,W,K,Q,E,S,P,V,I,C,Y,H,R,D,T),L109 (G,A,M,F,W,K,Q,E,S,P,V,I,C,Y,H,R,N,D,T), L110(G,A,M,F,W,K,Q,E,S, P, V, I, C, Y, H, R, N, D, T), Q111 (G, A, L, M, F, W, K, E, S, P, V, I, C, Y, H, R, N, D, T), E112 (G, A, L, M, F, W, K, Q, S, P, V, I, C, Y, H, R, N, D, T), V113 (G, A, L, M, F, W ,K,Q,E,S,P,I,C,Y,H,R,N,D,T),G114(A,L,M,F,W,K,Q,E,S,P,V,I,C,Y,H , R, N, D, T), C115 (G, A, L, M, F, W, K, Q, E, S, P, V, I, Y, H, R, N, D, T), N116 (G, A,L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、D、T)、H117(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、R、N、D、T)、A118(G、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、Q119(G、A、L、M、F、W、K、E、S、P、V、I、C、Y、H、R、N、D、T)、S120(G、A、L、M、F、W、K、Q、E、P、V、I、C、Y、H、R、N、D、T)、V121(G、A、L、M、F、W、K、Q、E、S、P、I、C、Y、H、R、N、D、T)、G122(A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、F123(G、A、L、M、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、S124(G、A、L、M、F、W、K、Q、E、P、V、I、C、Y、H、R、N、D、T)、T125(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D)、D126(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、T)、G127(A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、F128(G、A、L、M、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、A129(G、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、T130(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D)、T131(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D)、T132(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D)、T133(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D)、M134(G、A、L、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、R135(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、N、D、T)、L139(G、A、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、I140(G、A、L、M、F、W、K、Q、E、S、P、V、C、Y、H、R、N、D、T)、W141(G、A、L、M、F、K、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、V142(G、A、L、M、F、W、K、Q、E、S、P、I、C、Y、H、R、N、D、T)、T143(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D)、A144(G、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、R145(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、N、D、T)、M146(G、A、L、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、H147(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、R、N、D、T)、I162(G、A、L、M、F、W、K、Q、E、S、P、V、C、Y、H、R、N、D、T)、E163(G、A、L、M、F、W、K、Q、S、P、V、I、C、Y、H、R、N、D、T)、T164(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D)、W165(G、A、L、M、F、K、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、C166(G、A、L、M、F、W、K、Q、E、S、P、V、I、Y、H、R、N、D、T)、Q167(G、A、L、M、F、W、K、E、S、P、V、I、C、Y、H、R、N、D、T)、S168(G、A、L、M、F、W、K、Q、E、P、V、I、C、Y、H、R、N、D、T)、E169(G、A、L、M、F、W、K、Q、S、P、V、I、C、Y、H、R、N、D、T)、G170(A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、R171(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、N、D、T)、I172(G、A、L、M、F、W、K、Q、E、S、P、V、C、Y、H、R、N、D、T)、G173(A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、T174(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D)、R175(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、N、D、T)、R176(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、N、D、T)、D177(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、T)、W178(G、A、L、M、F、K、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、R191(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、N、D、T)、A192(G、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、T193(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D)、S194(G、A、L、M、F、W、K、Q、E、P、V、I、C、Y、H、R、N、D、T)、K195(G、A、L、M、F、W、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、W196(G、A、L、M、F、K、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、V197(G、A、L、M、F、W、K、Q、E、S、P、I、C、Y、H、R、N、D、T)、M198(G、A、L、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、M199(G、A、L、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、Q207(G、A、L、M、F、W、K、E、S、P、V、I、C、Y、H、R、N、D、T)、V209(G、A、L、M、F、W、K、Q、E、S、P、I、C、Y、H、R、N、D、T)、S210(G、A、L、M、F、W、K、Q、E、P、V、I、C、Y、H、R、N、D、T)、D212(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、T)、V213(G、A、L、M、F、W、K、Q、E、S、P、I、C、Y、H、R、N、D、T)、R214(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、N、D、T)、D215(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、T)、E216(G、A、L、M、F、W、K、Q、S、P、V、I、C、Y、H、R、N、D、T)、Y217(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、H、R、N、D、T)、L218(G、A、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、V219(G、A、L、M、F、W、K、Q、E、S、P、I、C、Y、H、R、N、D、T)、F220(G、A、L、M、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、C221(G、A、L、M、F、W、K、Q、E、S、P、V、I、Y、H、R、N、D、T)、P222(G、A、L、M、F、W、K, Q, E, S, V, I, C, Y, H, R, N, D, T), Q223 (G, A, L, M, F, W, K, E, S, P, V, I, C, Y, H, R, N, D, T), R226 (G, A, L, M, F, W, K, Q, E, S, P, V, I, C, Y, H, N, D, T), D262 (G, A, L, M, F, W, K ,Q,E,S,P,V,I,C,Y,H,R,N,T),M263(G,A,L,F,W,K,Q,E,S,P,V,I,C,Y,H,R,N,D, T), N264 (G, A, L, M, F, W, K, Q, E, S, P, V, I, C, Y, H, R, D, T), H266 (G, A, L, M, F, W, K, Q ,E,S,P,V,I,C,Y,R,N,D,T),V267(G,A,L,M,F,W,K,Q,E,S,P,I,C,Y,H,R,N,D,T ), N268 (G, A, L, M, F, W, K, Q, E, S, P, V, I, C, Y, H, R, D, T), N269 (G, A, L, M, F, W, K, Q, (E, S, P, V, I, C, Y, H, R, N, D, T), V270 (G, A, L, M, F, W, K, Q, E, S, P, V, I, C, Y, H, R, N, D, T), and Y297 (G, A, L, M, F, W, K, Q, E, S, P, V, I, C, H, R, N, D, T), wherein the position of the amino acid substitution is relative to SEQ ID NO: 1. ID NO: 1; or a DNA sequence encoding a FatA acyl-ACP thioesterase comprising at least a first amino acid substitution selected from the group consisting of: R176A, R176C, R176V, Y217L, L218C, S168R, G114S, F123N, R191C, C221F, N269Y, F123C, S168C, F220H, V121N, N269W, A118V, and A144Y, wherein the position of the amino acid substitution is relative to the position of the amino acid sequence provided as SEQ ID NO: 1.

[0092] In some embodiments, the DNA sequence encoding the FatA acyl-ACP thioesterase comprising at least a first amino acid substitution is a native FatA acyl-ACP thioesterase that has been edited to include the substitution. In some plant cell embodiments, the substitution comprises at least two amino acid substitutions selected from the group consisting of R176A, R176C, R176V, Y217L, L218C, S168R, G114S, F123N, R191C, C221F, N269Y, F123C, S168C, F220H, V121N, N269W, A118V, and A144Y, wherein the position of the amino acid substitution is relative to the position of the amino acid sequence provided as SEQ ID NO: 1.

[0093] FatA acyl-ACP thioesterase

[0094] In other embodiments, the disclosure relates to FatA acyl-ACP thioesterases that are, for example, not native or non-naturally occurring. For example, they may comprise at least a first amino acid substitution selected from the group consisting of S76 (G, A, L, M, F, W, K, Q, E, P, V, I, C, Y, H, R, N, D, T), L77 (G, A, M, F, W, K, Q, E, S, P, V, I, C, Y, H, R, N, D, T), T78 (G, A, L, M, F, W, K, Q, E, S, P, V, I, C, Y, H, R, N, D), D80 (G, A, L, M, F, W, K, Q, E, S, P, V, I, C, Y, H, R, N, T), G81 (A, L, M, F, W, K, Q, E, S, P, V, I, C, Y, H, R, N, D, T), N, D, T), L82 (G, A, M, F, W, K, Q, E, S, P, V, I, C, Y, H, R, N, D, T), S83 (G, A, L, M, F, W, K, Q, E, P, V, I, C, Y, H, R, N, D, T), Y84 (G, A, L, M, F, W, K, Q, E, S, P, V ,I,C,H,R,N,D,T),K85(G,A,L,M,F,W,Q,E,S,P,V,I,C,Y,H,R,N,D,T),E 86(G,A,L,M,F,W,K,Q,S,P,V,I,C,Y,H,R,N,D,T), F88(G,A,L,M,W,K,Q, E, S, P, V, I, C, Y, H, R, N, D, T), I106 (G, A, L, M, F, W, K, Q, E, S, P, V, C, Y, H, R, N, D, T), A107 (G, L, M, F, W, K, Q, E, S, P, V, I, C, Y, H, R, N, D, T), N108 (G, A, L, M, F, W, K, Q, E, S, P, V, I, C, Y, H, R, D, T), L109 (G, A, M, F, W, K, Q, E, S, P, V, I, C, Y, H, R, N, D, T), L110 (G, A, M, F, W, K, Q, E, S, P, V, I, C, Y, H, R, N, D, T), Q111 (G, A, L, M, F, W, K, E, S, P, V, I, C, Y, H, R, N, D, T), E112 (G, A, L, M, F, W, K, Q, S, P, V, I, C, Y, H, R, N, D, T), V113 (G, A, L, M, F, W, K, Q, E, S, P, I, C, Y, H, R, N, D, T), G114 (A, L, M, F, W, K, Q, E, S, P, V, I, C, Y, H, R, N, D, T) ,C115(G,A,L,M,F,W,K,Q,E,S,P,V,I,Y,H,R,N,D,T),N116(G,A,L,M,F,W、K、Q、E、S、P、V、I、C、Y、H、R、D、T)、H117(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、R、N、D、T)、A118(G、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、Q119(G、A、L、M、F、W、K、E、S、P、V、I、C、Y、H、R、N、D、T)、S120(G、A、L、M、F、W、K、Q、E、P、V、I、C、Y、H、R、N、D、T)、V121(G、A、L、M、F、W、K、Q、E、S、P、I、C、Y、H、R、N、D、T)、G122(A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、F123(G、A、L、M、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、S124(G、A、L、M、F、W、K、Q、E、P、V、I、C、Y、H、R、N、D、T)、T125(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D)、D126(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、T)、G127(A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、F128(G、A、L、M、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、A129(G、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、T130(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D)、T131(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D)、T132(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D)、T133(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D)、M134(G、A、L、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、R135(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、N、D、T)、L139(G、A、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、I140(G、A、L、M、F、W、K、Q、E、S、P、V、C、Y、H、R、N、D、T)、W141(G、A、L、M、F、K、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、V142(G、A、L、M、F、W、K、Q、E、S、P、I、C、Y、H、R、N、D、T)、T143(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D)、A144(G、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、R145(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、N、D、T)、M146(G、A、L、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、H147(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、R、N、D、T)、I162(G、A、L、M、F、W、K、Q、E、S、P、V、C、Y、H、R、N、D、T)、E163(G、A、L、M、F、W、K、Q、S、P、V、I、C、Y、H、R、N、D、T)、T164(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D)、W165(G、A、L、M、F、K、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、C166(G、A、L、M、F、W、K、Q、E、S、P、V、I、Y、H、R、N、D、T)、Q167(G、A、L、M、F、W、K、E、S、P、V、I、C、Y、H、R、N、D、T)、S168(G、A、L、M、F、W、K、Q、E、P、V、I、C、Y、H、R、N、D、T)、E169(G、A、L、M、F、W、K、Q、S、P、V、I、C、Y、H、R、N、D、T)、G170(A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、R171(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、N、D、T)、I172(G、A、L、M、F、W、K、Q、E、S、P、V、C、Y、H、R、N、D、T)、G173(A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、T174(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D)、R175(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、N、D、T)、R176(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、N、D、T)、D177(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、T)、W178(G、A、L、M、F、K、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、R191(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、N、D、T)、A192(G、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、T193(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D)、S194(G、A、L、M、F、W、K、Q、E、P、V、I、C、Y、H、R、N、D、T)、K195(G、A、L、M、F、W、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、W196(G、A、L、M、F、K、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、V197(G、A、L、M、F、W、K、Q、E、S、P、I、C、Y、H、R、N、D、T)、M198(G、A、L、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、M199(G、A、L、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、Q207(G、A、L、M、F、W、K、E、S、P、V、I、C、Y、H、R、N、D、T)、V209(G、A、L、M、F、W、K、Q、E、S、P、I、C、Y、H、R、N、D、T)、S210(G、A、L、M、F、W、K、Q、E、P、V、I、C、Y、H、R、N、D、T)、D212(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、T)、V213(G、A、L、M、F、W、K、Q、E、S、P、I、C、Y、H、R、N、D、T)、R214(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、N、D、T)、D215(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、T)、E216(G、A、L、M、F、W、K、Q、S、P、V、I、C、Y、H、R、N、D、T)、Y217(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、H、R、N、D、T)、L218(G、A、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、V219(G、A、L、M、F、W、K、Q、E、S、P、I、C、Y、H、R、N、D、T)、F220(G、A、L、M、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、C221(G、A、L、M、F、W、K、Q、E、S、P、V、I、Y、H、R、N、D、T)、P222(G、A、L、M、F、W、K、Q、E, S, V, I, C, Y, H, R, N, D, T), Q223 (G, A, L, M, F, W, K, E, S, P, V, I, C, Y, H, R, N, D, T) , R226 (G, A, L, M, F, W, K, Q, E, S, P, V, I, C, Y, H, N, D, T), D262 (G, A, L, M, F, W, K, Q, E, S, P, V, I, C, Y, H, R, N, T), M263 (G, A, L, F, W, K, Q, E, S, P, V, I, C, Y, H, R, N, D, T) , N264(G,A,L,M,F,W,K,Q,E,S,P,V,I,C,Y,H,R,D,T),H266(G,A,L,M,F,W,K,Q,E ,S,P,V,I,C,Y,R,N,D,T),V267(G,A,L,M,F,W,K,Q,E,S,P,I,C,Y,H,R,N,D,T), N268 (G, A, L, M, F, W, K, Q, E, S, P, V, I, C, Y, H, R, D, T), N269 (G, A, L, M, F, W, K, Q, E , S, P, V, I, C, Y, H, R, N, D, T), V270 (G, A, L, M, F, W, K, Q, E, S, P, I, C, Y, H, R, N, D, T), and Y297 (G, A, L, M, F, W, K, Q, E, S, P, V, I, C, H, R, N, D, T), wherein the position of the amino acid substitution is relative to the position of the amino acid sequence provided as SEQ ID NO:1. Exemplary FatA acyl-ACP thioesterases include those having at least one of the following mutations: R176A, R176C, R176V, Y217L, L218C, S168R, G114S, F123N, R191C, C221F, N269Y, F123C, S168C, F220H, V121N, N269W, A118V, and A144Y, wherein the position of the amino acid substitution is relative to the position of the amino acid sequence provided as SEQ ID NO: 1. In another embodiment, the FatA acyl-ACP thioesterase comprises an amino acid substitution selected from the group consisting of: R176A-R191C, R176C-R191C, and R176V-R191C. In another embodiment, the FatA acyl-ACP thioesterase comprises an amino acid sequence selected from the group consisting of SEQ ID NOs: 15-19. In another embodiment, the FatA acyl-ACP thioesterase is at least 70%, at least 71%, at least 72%, at least 73%, at least 74%, at least 75%, at least 76%, at least 77%, at least 78%, at least 79%, at least 80%, at least 81%, at least 82%, at least 83%, at least 84%, at least 85%, at least 86%, at least 87%, at least 88%, at least 89%, at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, at least 100%, at least 101%, at least 102%, at least 103%, at least 104%, at least 105%, at least 106%, at least 107%, at least 108%, at least 109%, at least 110%, at least 111%, at least 112%, at least 113%, at least 114%, at least 115%, at least 116%, at least 117%, at least 118%, at least 119%, at leastA non-natural amino acid sequence having at least one of at least 84%, at least 85%, at least 86%, at least 87%, at least 88%, at least 89%, at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98%, and at least 99% sequence identity. In typical embodiments, the FatA acyl-ACP thioesterase is tolerant to a FatA acyl-ACP thioesterase inhibiting herbicide.

[0095] The present invention further relates to the use of a polynucleotide comprising a region encoding a FatA acyl-ACP thioesterase as a selectable marker in plant transformation and the use of a polynucleotide comprising a region encoding a FatA acyl-ACP thioesterase in the production of plants that are tolerant to herbicides that act in whole or in part by inhibiting the FatA acyl-ACP thioesterase.

[0096] The present invention further relates to the use of FatA acyl-ACP thioesterase inhibitors as selection agents in plant transformation and the use of recombinant FatA acyl-ACP thioesterase in an in vitro screening method for identifying FatA acyl-ACP thioesterase inhibiting herbicides.

[0097] Many features and advantages, along with structural and functional details, have been set forth in the foregoing description. However, the disclosure is illustrative only, and changes in detail may be made within the principles of the invention, particularly in the arrangement of features or steps of the methods disclosed herein (within the full range indicated by the broad general meaning of the clauses expressing the overall claims). Furthermore, the various embodiments are not intended to be mutually exclusive, for example, features may be considered interchangeable, unless such an interchange would render the embodiment inoperative.

[0098] Various embodiments of the invention will become more apparent from the following non-limiting examples.

[0099] Example 1. Expression and Assay of FatA Acyl-ACP Thioesterase

[0100] The following DNA sequence was synthesized, which was optimized for E. coli codon usage and encodes a mature Fat A polypeptide derived from Arabidopsis thaliana with a his-tag at the C-terminus (SEQ ID No: 15), including 5' NdeI and 3' XhoI restriction sites.

[0101] This is cloned into the Escherichia coli expression plasmid pET24a (Novagen company (Novagen)) via NdeI and XhoI restriction sites, and the resulting plasmid is transformed into Escherichia coli BL21 (DE3) and then maintained with 50 μg / ml kanamycin. Escherichia coli BL21 (DE3) competent cells are transformed according to the following method. The competent cells of 100 μl aliquots are thawed, premixed with the β-mercaptoethanol of 1.7 μl on ice and then incubated 30min with the DNA of 1-50ng on ice under vortexing gently. Each conversion reaction is briefly (45s) warmed to 42 ℃ before returning to ice, and then mixed with the SOC culture medium of 0.9ml preheated to 42 ℃. Then the cell suspension is incubated at 37 ℃ for 1 hour, shaken at 250rpm, and then 5 and 50 μl aliquots are plated on the LB agar plate containing 50 μg / ml kanamycin. The bacterium colony of picking conversion after overnight growth.After pre-growth in initial seed culture, transformed cell is transferred to Formedium self-induction medium (it has super broth (Terrific broth) matrix and comprises trace element), and then culture is followed by shaking overnight growth at 20 ℃ in 1L flask.After growth, the cell paste of about 10g weight in wet condition is resuspended in 50ml lysis buffer, and this buffer is 25mM Hepes, pH 7.5, contains 25mM imidazoles, 500mM NaCl and 0.5mM TCEP (tris (2-carboxyethyl) phosphine).Cell is stirred about 30min to resuspend and then use constant system cell crusher to crack under the pressure of 20000psi.Cell lysate is clarified by centrifugal rotation 30min at 4 ℃ with 25000xg in Beckman (Beckman) JA 25.5 rotor. The lysate of clarification is then applied to the 5ml HisTrap Crude FF post of balance in 25mM Hepes buffer (pH 7.5, containing 25mM imidazoles, 500mM NaCl and 0.5mM TCEP). The protein of elution combination is then washed with this buffer of 20 column volumes and then in 3.5 column volumes of 25mM Hepes buffer (pH 7.5, containing 500mM imidazoles, 500mM NaCl and 0.5mMTCEP). The protein of wash-out is then further purified and exchanged to 25mM Hepes buffer (pH 7.5, containing 150mM NaCl and 0.5mM TCEP) along GE 26 / 60S200SEC post downwards. Before storing as freezing beads, 10%v / v glycerol is added in the fraction merged. Use Nanodrop ME52070 to determine protein concentration.The protein so obtained typically runs as a single major band (corresponding to the expected molecular weight) by SDS PAGE stained with Coomassie Blue and typically has a purity of > about 50% based on gel densitometry.

[0102] Alternatively, E. coli colonies transformed with constructs expressing FatA can be picked from LB plus kanamycin plates and grown overnight in 0.5ml Terrific Broth in 96 deep-well plates to achieve high-throughput screening. Each of these seed cultures (25ul) is then used to inoculate fresh 96 deep-well plates containing 1ml AIM culture medium. The 96 deep-well plates containing AIM are incubated in a shaking incubator for 3 hours (37°C, 900rpm) and then transferred to a 20°C shaking incubator (900rpm) overnight. The plate is then slowly rotated and the supernatant is discarded. The precipitate is resuspended in 250ul washing buffer (PBS) and then slowly rotated. The supernatant is then discarded and the precipitate is frozen at -80°C. The pellet was then thawed and resuspended in 250ul lysis buffer (50mM Tris pH 8, 5% glycerol, 50mM NaCl and 0.6% vol / vol Lysonase reagent (Merck, Germany) and gently shaken for 20 minutes at room temperature. The lysate was then centrifuged (4450rpm, 5 minutes at 4°C). 100ul of the supernatant lysate was removed. 600-fold dilutions of the lysate were then prepared using a buffer consisting of 50mM Tris pH 8, 150mM NaCl, 5mM EDTA and 0.1mg / ml beta casein.

[0103] To determine the level of FatA thioesterase activity in the presence of test compounds, an assay buffer consisting of 50 mM Tris-HCl pH 8.0, 0.15 M NaCl, 5 mM EDTA, 10 μM oleoyl-CoA was combined with the enzyme (1-80 nM Arabidopsis thaliana FatA thioesterase) to a final volume of 100 μl. The assay was performed in a black 96-well microtiter plate into which the test compounds dissolved in DMSO (1% v / v final assay concentration) had been dispensed prior to the addition of the other assay components. Once all assay components were added, the plate was incubated at room temperature for 5 min, during which time the reaction proceeded at a linear rate. Enzyme activity was simultaneously stopped by the addition of a 10 μl solution of 220 μM 7-diethylamino-3-(4′-maleimidophenyl)-4-methylcoumarin (“CPM”) dissolved in 50% v / v ethanol, and the detection reagent was added. After allowing the CoASH formed by the enzyme to react almost completely with CPM for an appropriate time, the fluorescence was read in a microplate reader using excitation and emission wavelengths of 390nm and 470nm, respectively. The assay signal associated with the maximum (uninhibited) enzyme activity was determined by the 1% v / v final concentration of DMSO present in the reaction, and the assay signal associated with complete enzyme inhibition was determined by the wells to which no enzyme was added. The effect of the test compound on the enzyme activity was then calculated by normalizing the signal according to the maximum and minimum activity controls and by fitting the dose-response curve using nonlinear regression to obtain an IC50 value. Example data are shown in Table 1.

[0104] For the determination of the kinetic parameters of the FatA enzyme with oleoyl-CoA as substrate, the determination was performed essentially as described above to test the inhibitor compounds, but the method was changed as follows. Oleoyl-CoA was omitted from the determination premix (master mix) and added as a separate component to reach a final concentration of 40 μM, 23.5 μM, 13.8 μM, 8.1 μM, 4.8 μM, 2.8 μM and 1.7 μM (i.e., 1.7x dilution scheme). The measured values ​​measured at 0, 20, 40, 60, 90 and 120 s after adding the enzyme were used to determine the level of enzyme activity from the slope (initial linear rate) of the progress curve. The kinetic parameters were then calculated using the Michaelis-Menten model implemented in the GraphPad Prism software.

[0105] Table 1. pIC50 values ​​of FatA inhibitors cypermethrin and oxazolidinone.

[0106]

[0107] Example 2. FatA sequences and expression in plants

[0108] Arabidopsis thaliana FatA or its ortholog (see full-length FatA sequence, including chloroplast transit peptide), such as SEQ ID No. 1, 2, 3, 4, 5, 6 or 7 expressed in transgenic tobacco. DNA sequences encoding these polypeptides (optimized for tobacco, or optionally codon-optimized according to target crops such as soybean) are prepared synthetically. Each sequence is designed to include a 5' fusion with a TMVΩ 5' leader sequence, and to flank them with XhoI at the 5' end and KpnI at the 3' end to facilitate direct cloning into binary vectors suitable for Agrobacterium-based plant transformation.

[0109] In one example, an expression cassette (comprising the TMVΩ 5' leader sequence and the target FatA encoding gene) is excised using XhoI / KpnI and cloned into similarly digested pBIN 19 (Bevan, Nucl. Acids Res. (1984)) (after the dual enhanced 35S promoter and before the NOS 3' transcription terminator) and then transformed into E. coli DH5α competent cells. DNA recovered from the E. coli is used to transform Agrobacterium tumefaciens LBA4404, and transformed bacteria are selected on a medium containing rifampicin and kanamycin. Tobacco tissue is subjected to Agrobacterium-mediated transformation using methods well described in the art or as described herein. For example, a mother plate of Agrobacterium tumefaciens containing a binary vector expressing FatA acyl-ACP thioesterase is used to inoculate 10 ml LB (L broth) containing 100 mg / l rifampicin 50 mg / l kanamycin (using a single colony). The culture was incubated overnight at 28°C with shaking at 200 rpm. The entire overnight culture was used to inoculate a 50 ml volume of LB containing the same antibiotic. Once again, the culture was grown overnight at 28°C with shaking at 200 rpm. The Agrobacterium cells were precipitated by centrifugation at 3000 rpm for 15 minutes and then resuspended in a medium containing 30 g / l sucrose, pH 5.9 of MS (Murashige and Skoog) to OD (600 nM) = 0.6. The suspension was distributed to petri dishes in 25 ml aliquots.

[0110] The tobacco shoot culture of clone micropropagation is used to excise tender leaves (not yet fully expanded). Midrib and outer leaf margin are removed and discarded, and remaining blade is cut into 1 square centimeter. These blades are transferred to the Agrobacterium suspension and continue for 20 minutes. Then the explant is removed, patted on sterile filter paper to remove excessive suspension, then transferred to solid NBM medium (MS medium containing 30g / l sucrose, 1mg / l BAP (benzoic acid purine) and 0.1mg / l NAA (naphthaleneacetic acid) under pH 5.9 and solidified with 8g / l plant agar), the abaxial surface of each explant is contacted with this medium. Each flat plate is transformed into about 7 explants, then the flat plate is sealed and in the illumination incubator at 25 ℃, keeps 16 hours photoperiod and continues for 3 days.

[0111] The explants were then transferred to NBM medium containing 100 mg / l kanamycin plus antibiotics to further prevent the growth of Agrobacterium (200 mg / l Timentin with 250 mg / l carbenicillin). Further subcultures were then performed every 2 weeks on this same medium.

[0112] When shoots begin to regenerate from callus leaf explants, these are moved to shoot elongation medium (MS medium, 30 g / l sucrose, 8 g / l plant agar, 100 mg / l kanamycin, 200 mg / l timentin, 250 mg / l carbenicillin, pH 5.9). These stable transgenic plants easily root within 2 weeks. In order to provide multiple plants for each event, to ultimately allow more than one herbicide test for each transgenic plant, all rooted shoots are micropropagated to produce 3 or more rooted clones.

[0113] Putative transgenic plants that were rooting and showing vigorous shoot growth on media combined with kanamycin were analyzed by PCR using primers that amplified a 500 bp fragment specific for the FatA acyl-ACP thioesterase transgene of interest. Evaluation of this same primer set on untransformed tobacco conclusively showed that these primers did not amplify any sequence from the native tobacco genome.

[0114] The transformed shoots are divided into 2 or 3 clones and regenerated from kanamycin resistant callus. These shoots are rooted on MS agar containing kanamycin. The rooted explants that survive are regenerated roots, thereby providing about 40-50 kanamycin resistant and PCR positive events from each event.

[0115] Once rooted, the plantlets were transferred from the agar and potted into 3-inch round pots with 50% peat, 50% John Innes Soil No. 3 with slow-release fertilizer, watered regularly and established in the greenhouse for 8 to 12 days. Greenhouse conditions were about 24°C-27°C during the day, 18°C-21°C at night, and a photoperiod of about 14 h. Humidity was adjusted to about 65% and the light level used was up to 2000 μmol / m at bench level. 2 .

[0116] Therefore produced the transgenic colony of about 40 kinds of tobacco plants that comprise the gene of coding full-length FatA gene (for example Seq ID No 8).Based on identical size, from each colony, select plant, and carry out ELISA or Mass Western test to monitor protein transgenic FatA expression level.Select the TO strain of highest expression to carry out selfing (self) and produce T1 seed and T2 strain and seed in a normal manner.To test sprouting on the agar plate containing the FatA inhibitory herbicide of a series of concentration from the seed of highest expression strain, as taught by this paper example, and resistant plant strain is selected as the minimum damage to root growth and morphology under the herbicide of highest concentration.Compare with the wild type of similar growth and processing and invalid separation plant, resistant plant strain shows the dose response of weeding damage about FatA inhibitor, and this dose response moves to the right.

[0117] In addition to the testing procedures described above, resistant clonal plants of resistant primary transformants can also be selected and identified at the initial T0 stage and tested by re-rooting in agar under a range of concentrations of FatA-inhibiting herbicides.

[0118] Example 3. Selection of FatA enzyme variants with increased herbicide tolerance.

[0119] Table X: Amino acid positions selected for single site saturation variant library screening.

[0120] S76 L77 T78 D80 G81 L82 S83 Y84 K85 E86 F88 I106 A107 N108 L109 L110 Q111 E112 V113 G114 C115 N116 H117 A118 Q119 S120 V121 G122 F123 S124 T125 D126 G127 F128 A129 T130 T131 T132 T133 M134 R135 L139 I140 W141 V142 T143 A144 R145 M146 H147 I162 E163 T164 W165 C166 Q167 S168 E169 G170 R171 I172 G173 T174 R175 R176 D177 W178 R191 A192 T193 S194 K195 W196 V197 M198 M199 Q207 V209 S210 D212 V213 R214 D215 E216 Y217 L218 V219 F220 C221 P222 Q223 R226 D262 M263 N264 H266 V267 N268 N269 V270 Y297

[0121] Gene synthesis (Twist Bioscience, U.S.) method is used to create a single site saturation variant library for the codons of the amino acid positions listed in the coding table X. As in Example 1, the variant sequence is cloned into pET24a, expressed in 96-well deep plates, and measured in the presence and absence of FatA inhibitory herbicides as described in Example 1. Compared to the enzyme activity seen in the DMSO control, based on the inhibition level seen in the presence of FatA inhibitory herbicides, each variant based on FatA is scored. For any variant used that demonstrates significantly increased tolerance to herbicides, after inoculation in the relevant wells of the original TB 96 deep-well plates, fresh 5ml overnight LB plus kanamycin cultures are cultivated, and plasmid DNA is extracted using GeneJet Miniprep kit (ThermoScientific, UK). The FatA gene is then fully sequenced to reveal the target mutation. Screening has produced many hits, so these are further characterized as described in Example 4.

[0122] Example 4. Further biochemical characterization of selected FatA variants.

[0123] FatA variant enzymes were prepared from 1 L of E. coli growth and assayed to determine enzyme kinetics as described in Example 1. Table X3 shows the improved tolerance to the FatA inhibitors cyproconazole and oxazithromycin. The IC50 of cyproconazole for the R176 variants could not be determined because these variants were highly resistant to this herbicide.

[0124] Table X3: Enzyme kinetic data for selected Fat variants.

[0125]

[0126] Example 5. Herbicide tolerance testing of FatA variants in transgenic tobacco

[0127] As described in Example 2, use for example through mutation to create the construct for expressing FatA in tobacco with the SEQ ID 1 that carries the mutation of purpose.Produce transgenic tobacco strain as described in Example 2 subsequently, and select the best expression event of every kind of construct by the Mass Western quantitative proteomics detection that SEQ ID 1 has specific peptide.Then in the presence and absence of cyproconazole herbicide, selected event is carried out clonal propagation and grown in agar.The transgenic strain of non-converted tobacco (dead spot three-life tobacco (Samsun var.)) and overexpression non-mutated SEQ 1 Arabidopsis thaliana FatA is included on the plate as a control.After being transferred to agar medium 7 days and 14 days, root growth is carried out visual evaluation score.The results are shown in Table X2.

[0128] Table X2. Root growth intensity of transgenic tobacco events in the presence / absence of cyproconazole.

[0129]

[0130]

[0131] Plants were further cloned from the SEQ ID 1+R176A+R191C double mutant event and tested against higher doses of cyproconazole. In these experiments, plants were grown in 15 ml test tubes containing plant agar and different doses of herbicides. Root growth was visually scored again 7 and 14 days after being transferred to growth medium. The results are shown in Table X4.

[0132] Table X4. Root growth intensity of transgenic tobacco events in the presence / absence of cyproconazole.

[0133]

[0134]

[0135] The R176A+R191C double mutant plants continued to grow vigorously at all tested cyproconazole doses, producing a strong root structure indicating that this FatA variant provides strong tolerance to the herbicide. In contrast, plants from the R176A event were more severely affected by the herbicide, producing significantly lower root mass than the double mutant R176A+R191C.

[0136] Example 6. Genome editing of FatA in crops

[0137] Editing maize genomic DNA encoding FatA acyl-ACP thioesterase to produce maize plants tolerant to FatA-inhibiting herbicides. Use CpF1 (Cas12) and at least one gRNA to create a vector construct (e.g., Figure 2 The vector (SEQ ID NO: 25) was used to mediate the following amino acid changes on exon 3 of the native maize FatA acyl-ACP thioesterase: R176A-R191C. Maize immature embryos were transformed with the vector using techniques well known in the art, such as particle bombardment or Agrobacterium-mediated transformation. Putative edited plants were screened with cyproconazole to assess resistance relative to unedited controls.

Claims

1. A method for selectively controlling weeds at a locus containing crop plants and weeds, the method comprising: A weed controlling amount of a pesticide composition is applied to the locus, the pesticide composition comprising a FatA acyl-ACP thioesterase inhibiting herbicide, wherein the crop plants are modified so that they comprise a FatA acyl-ACP thioesterase that provides the crop plants with tolerance to the FatA acyl-ACP thioesterase inhibiting herbicide.

2. The method of claim 1, wherein the crop plant is modified with a recombinant polynucleotide that provides the FatA acyl-ACP thioesterase, and the FatA acyl-ACP thioesterase provides the crop plant with tolerance to the FatA acyl-ACP thioesterase-inhibiting herbicide.

3. The method of claim 2, wherein the FatA acyl-ACP thioesterase is derived from a species selected from the group consisting of Arabidopsis species, Triticum species, Hordeum species, Oryza species, Zea mays species, and Glycine max species.

4. The method of claim 2 or 3, wherein the FatA acyl-ACP thioesterase is derived from Arabidopsis thaliana, Triticum aestivum (Wheat), Hordeum vulgare (Barley), Oryza sativa (Rice), Zea mays (Maize), or Glycinemax (Soybean).

5. The method of claim 3 or 4, wherein the FatA acyl-ACP thioesterase is selected from: (a) the group consisting of SEQ ID NOs: 1-7 and 15-19; or (b) a FatA acyl-ACP thioesterase having at least one of at least 70%, at least 71%, at least 72%, at least 73%, at least 74%, at least 75%, at least 76%, at least 77%, at least 78%, at least 79%, at least 80%, at least 81%, at least 82%, at least 83%, at least 84%, at least 85%, at least 86%, at least 87%, at least 88%, at least 89%, at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98%, and at least 99% sequence identity to a sequence selected from SEQ ID NOs: 1-7 and 15-19.

6. The method according to claim 3, 4 or 5, wherein the FatA acyl-ACP thioesterase comprises at least a first amino acid substitution selected from the group consisting of: S76 (G, A, L, M, F, W, K, Q, E, P, V, I, C, Y, H, R, N, D, T), L77 (G, A, M, F, W, K, Q, E, S, P, V, I, C, Y, H, R, N, D, T), T78 (G, A, L, M, F, W, K, Q, E, S, P, V, I, C, Y, H, R, N, D), D80 (G, A, L, M, F, W, K, Q, E, S, P, V, I, C, Y, H, R, N, T), G81 (A, L, M, F, W, K, Q, E, S, P, V, I, C, Y, H, R, N, D, T), L82 (G, A, M, F, W, K, Q, E, S, P, V, I, C, Y, H, R, N, D, T), S83 (G, A, L, M, F, W, K, Q, E, P, V, I, C, Y, H, R, N, D, T), Y84 (G, A, L, M, F, W, K, Q, E, S, P, V, I, C, H, R, N, D, T), K85 (G, A, L, M, F, W, Q, E, S, P, V, I, C, Y, H, R, N, D, T), E86 (G, A, L, M, F, W, K, Q, S, P, V, I, C, Y, H, R, N, D, T), F88 (G, A, L, M, W, K, Q, E, S, P, V, I, C, Y, H, R, N, D, T), I106 (G, A, L, M, F, W, K, Q, E, S, P, V, C, Y, H, R, N, D, T), A107 (G, L, M, F, W, K, Q, E, S, P, V, I, C, Y, H, R, N, D, T), N108 (G, A, L, M, F, W, K, Q, E, S, P, V, I, C, Y, H, R, D, T), L109 (G, A, M, F, W, K, Q, E, S, P, V, I, C, Y, H, R, N, D, T), L110 (G, A, M, F, W, K, Q, E, S, P, V, I, C, Y, H, R, N, D, T), Q111 (G, A, L, M, F, W, K, E, S, P, V, I, C, Y, H, R, N, D, T), E112 (G, A, L, M, F, W, K, Q, S, P, V, I, C, Y, H, R, N, D, T), V113 (G, A, L, M, F, W, K, Q, E, S, P, I, C, Y, H, R, N, D, T), G114 (A, L, M, F, W, K, Q, E, S, P, V, I, C, Y, H, R, N, D, T), C115 (G, A, L, M, F, W, K, Q, E, S, P, V, I, Y, H, R, N, D, T), N116 (G, A, L, M, F, W, K, Q, E, S, P, V, I,C、Y、H、R、D、T)、H117(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、R、N、D、T)、A118(G、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、Q119(G、A、L、M、F、W、K、E、S、P、V、I、C、Y、H、R、N、D、T)、S120(G、A、L、M、F、W、K、Q、E、P、V、I、C、Y、H、R、N、D、T)、V121(G、A、L、M、F、W、K、Q、E、S、P、I、C、Y、H、R、N、D、T)、G122(A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、F123(G、A、L、M、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、S124(G、A、L、M、F、W、K、Q、E、P、V、I、C、Y、H、R、N、D、T)、T125(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D)、D126(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、T)、G127(A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、F128(G、A、L、M、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、A129(G、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、T130(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D)、T131(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D)、T132(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D)、T133(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D)、M134(G、A、L、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、R135(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、N、D、T)、L139(G、A、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、I140(G、A、L、M、F、W、K、Q、E、S、P、V、C、Y、H、R、N、D、T)、W141(G、A、L、M、F、K、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、V142(G、A、L、M、F、W、K、Q、E、S、P、I、C、Y、H、R、N、D、T)、T143(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D)、A144(G、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、R145(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、N、D、T)、M146(G、A、L、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、H147(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、R、N、D、T)、I162(G、A、L、M、F、W、K、Q、E、S、P、V、C、Y、H、R、N、D、T)、E163(G、A、L、M、F、W、K、Q、S、P、V、I、C、Y、H、R、N、D、T)、T164(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D)、W165(G、A、L、M、F、K、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、C166(G、A、L、M、F、W、K、Q、E、S、P、V、I、Y、H、R、N、D、T)、Q167(G、A、L、M、F、W、K、E、S、P、V、I、C、Y、H、R、N、D、T)、S168(G、A、L、M、F、W、K、Q、E、P、V、I、C、Y、H、R、N、D、T)、E169(G、A、L、M、F、W、K、Q、S、P、V、I、C、Y、H、R、N、D、T)、G170(A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、R171(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、N、D、T)、I172(G、A、L、M、F、W、K、Q、E、S、P、V、C、Y、H、R、N、D、T)、G173(A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、T174(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D)、R175(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、N、D、T)、R176(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、N、D、T)、D177(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、T)、W178(G、A、L、M、F、K、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、R191(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、N、D、T)、A192(G、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、T193(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D)、S194(G、A、L、M、F、W、K、Q、E、P、V、I、C、Y、H、R、N、D、T)、K195(G、A、L、M、F、W、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、W196(G、A、L、M、F、K、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、V197(G、A、L、M、F、W、K、Q、E、S、P、I、C、Y、H、R、N、D、T)、M198(G、A、L、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、M199(G、A、L、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、Q207(G、A、L、M、F、W、K、E、S、P、V、I、C、Y、H、R、N、D、T)、V209(G、A、L、M、F、W、K、Q、E、S、P、I、C、Y、H、R、N、D、T)、S210(G、A、L、M、F、W、K、Q、E、P、V、I、C、Y、H、R、N、D、T)、D212(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、T)、V213(G、A、L、M、F、W、K、Q、E、S、P、I、C、Y、H、R、N、D、T)、R214(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、N、D、T)、D215(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、T)、E216(G、A、L、M、F、W、K、Q、S、P、V、I、C、Y、H、R、N、D、T)、Y217(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、H、R、N、D、T)、L218(G、A、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、V219(G、A、L、M、F、W、K、Q、E、S、P、I、C、Y、H、R、N、D、T)、F220(G、A、L、M、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、C221(G、A、L、M、F、W、K、Q、E、S、P、V、I、Y、H、R、N、D、T)、P222(G、A、L、M、F、W、K、Q、E、S、V、I、C、Y、H、R、N、D, T), Q223 (G, A, L, M, F, W, K, E, S, P, V, I, C, Y, H, R, N, D, T), R226 (G, A, L, M, F, W, K, Q, E, S, P, V, I, C, Y, H, N, D, T), D262 (G, A, L, M, F, W, K, Q, E, S, P, V, I, C, Y, H, R, N, T), M263 (G, A, L, F, W, K, Q, E, S, P, V, I, C, Y, H, R, N, D, T), N264 (G, A, L, M, F, W, K, Q, E, S, P, V, I, C, Y, H, R, D, T), H266 (G, A, L, M, F, W, K, Q, E, S, P, V, I, C, Y, H, R, N, D, T), V267 (G, A, L, M, F, W, K, Q, E, S, P, I, C, Y, H, R, N, D, T), N268 (G, A, L, M, F, W, K, Q, E, S, P, V, I, C, Y, H, R, D, T), N269 (G, A, L, M, F, W, K, Q, E, S, P, V, I, C, Y, H, R, N, D, T), V270 (G, A, L, M, F, W, K, Q, E, S, P, I, C, Y, H, R, N, D, T), and Y297 (G, A, L, M, F, W, K, Q, E, S, P, V, I, C, H, R, N, D, T), wherein the positions of the amino acid substitutions are relative to those of SEQ ID NO:

1. ID NO: 1 provides the position of the amino acid sequence.

7. The method of any of the preceding claims, wherein the FatA acyl-ACP thioesterase comprises at least a first amino acid substitution selected from the group consisting of R176A, R176C, R176V, Y217L, L218C, S168R, G114S, F123N, R191C, C221F, N269Y, F123C, S168C, F220H, V121N, N269W, A118V, and A144Y, wherein the position of the amino acid substitution is relative to the position of the amino acid sequence provided as SEQ ID NO:

1.

8. The method of any of the preceding claims, wherein the FatA acyl-ACP thioesterase comprises at least 2, at least 3, at least 4, at least 5, at least 6, or at least 7 of the amino acid substitutions R176A, R176C, R176V, Y217L, L218C, S168R, G114S, F123N, R191C, C221F, N269Y, F123C, S168C, F220H, V121N, N269W, A118V, and A144Y, wherein the positions of the amino acid substitutions are relative to the positions of the amino acid sequence provided as SEQ ID NO:

1.

9. The method of any of the preceding claims, wherein the FatA acyl-ACP thioesterase comprises at least one pair of amino acid substitutions selected from the group consisting of: R176A and R191C, R176C and R191C, and R176V and R191C, wherein the positions of the amino acid substitutions are relative to the position of the amino acid sequence provided as SEQ ID NO:

1.

10. The method of any one of the preceding claims, wherein the FatA acyl-ACP thioesterase is provided by editing an endogenous gene.

11. The method according to any one of the preceding claims, wherein the FatA acyl-ACP thioesterase inhibiting herbicide is selected from the group consisting of compounds having formula (I): Where R 1 and R 2 Each is independently H, C1-C6 alkyl, C1-C6 haloalkyl, halogen or cyano, preferably Me, Cl, F or H.

12. The method according to any one of the preceding claims, wherein the FatA acyl-ACP thioesterase inhibiting herbicide is selected from the group consisting of cyproconazole and oxazithromycin.

13. The method of any one of the preceding claims, wherein the crop plant comprises a recombinant polynucleotide encoding an additional herbicide tolerance enzyme, wherein the additional herbicide tolerance enzyme is selected from the group consisting of: 5-enolpyruvylshikimate-3-phosphate synthase (EPSPS), glyphosate acetyltransferase (GAT), cytochrome P450, phosphinothricin acetyltransferase (PAT), acetolactate synthase (ALS), protoporphyrinogen oxidase (PPO), hydroxyphenylpyruvate dioxygenase (HPPD), and a dicamba degrading enzyme.

14. The method according to any one of the preceding claims, wherein the pesticide composition comprises one or more additional herbicides, wherein the one or more additional herbicides are selected from the group consisting of: glyphosate (including agrochemically acceptable salts thereof); glufosinate (including agrochemically acceptable salts thereof); chloroacetanilides, for example, alachlor, acetochlor, isopropyl metolachlor, S-isopropyl metolachlor; photosystem II inhibitors, for example, triazines such as ametryn, atrazine, cyanamide azine and terbuthylazine, triazinones such as hexazinone and metribuzin, and ureas such as chlorotoluron, diuron, isoproturon, linuron and butylthiocarb; ALS-inhibitors, for example sulfonylureas such as amidosulfuron, chlorsulfuron, fluazifop-methyl, clopyrasulfuron, nicosulfuron, primisulfuron, prosulfuron, rimsulfuron, ethersulfuron-methyl, trifloxysulfuron and trifloxysulfuron; diphenyl ethers, for example, acifluorfen and fomesafen; HPPD-inhibiting herbicides, such as mesotrione and flupyralidone; dicamba and 2,4D.

15. A recombinant polynucleotide comprising (i) a region encoding a modified FatA acyl-ACP thioesterase operably linked to a plant operable promoter.

16. The recombinant polynucleotide of claim 15, wherein the FatA acyl-ACP thioesterase is selected from the group consisting of: SEQ ID NO: 8-14, or SEQ ID NO: 20-23, or A DNA sequence encoding a FatA acyl-ACP thioesterase comprising at least a first amino acid substitution, said amino acid substitution being selected from the group consisting of: S76(G, A, L, M, F, W, K, Q, E, P, V, I, C, Y, H, R, N, D, T), L77(G, A, M, F, W, K, Q, E, S, P, V, I, C, Y, H, R, N, D, T), T78(G, A, L, M, F, W, K, Q, E, S, P, V, I, C, Y, H, R, N, D), D80(G, A, L, M, F, W, K, Q, E, S, P, V, I, C, Y, H, R, N, T), G81(A, L, M, F, W, K, Q, E, S, P, V, I, C, Y, H, R, N, D, T), L82(G, A, M, F, W, K, Q, E, S, P, V, I, C, Y, H, R, N, D, T), S83(G, A, L, M, F, W, K, Q, E, P, V, I, C, Y, H, R, N, D, T), Y84(G, A, L, M, F, W, K, Q, E, S, P, V, I, C, H, R, N, D, T), K85(G, A, L, M, F, W, Q, E, S, P, V, I, C, Y, H, R, N, D, T), E86(G, A, L, M, F, W, K, Q, S, P, V, I, C, Y, H, R, N, D, T), F88(G, A, L, M, W, K, Q, E, S, P, V, I, C, Y, H, R, N, D, T), I106(G, A, L, M, F, W, K, Q, E, S, P, V, C, Y, H, R, N, D, T), A107(G, L, M, F, W, K, Q, E, S, P, V, I, C, Y, H, R, N, D, T), N108(G, A, L, M, F, W, K, Q, E, S, P, V, I, C, Y, H, R, D, T), L109(G, A, M, F, W, K, Q, E, S, P, V, I, C, Y, H, R, N, D, T), L110(G, A, M, F, W, K, Q, E, S, P, V, I, C, Y, H, R, N, D, T), Q111(G, A, L, M, F, W, K, E, S, P, V, I, C, Y, H, R, N, D, T), E112(G, A, L, M, F, W, K, Q, S, P, V, I, C, Y, H, R, N, D, T), V113(G, A, L, M, F, W, K, Q, E, S, P, I, C, Y, H, R, N, D, T), G114(A, L, M, F, W, K, Q, E, S, P, V, I, C, Y, H, R, N, D, T), C115(G, A, L, M, F, W, K, Q, E, S, P, V, I, Y, H, R, N, D, T), N116(G, A, L, M, F, W, K, Q, E, S, P, V, I, C, Y, H,R、D、T)、H117(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、R、N、D、T)、A118(G、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、Q119(G、A、L、M、F、W、K、E、S、P、V、I、C、Y、H、R、N、D、T)、S120(G、A、L、M、F、W、K、Q、E、P、V、I、C、Y、H、R、N、D、T)、V121(G、A、L、M、F、W、K、Q、E、S、P、I、C、Y、H、R、N、D、T)、G122(A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、F123(G、A、L、M、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、S124(G、A、L、M、F、W、K、Q、E、P、V、I、C、Y、H、R、N、D、T)、T125(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D)、D126(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、T)、G127(A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、F128(G、A、L、M、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、A129(G、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、T130(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D)、T131(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D)、T132(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D)、T133(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D)、M134(G、A、L、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、R135(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、N、D、T)、L139(G、A、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、I140(G、A、L、M、F、W、K、Q、E、S、P、V、C、Y、H、R、N、D、T)、W141(G、A、L、M、F、K、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、V142(G、A、L、M、F、W、K、Q、E、S、P、I、C、Y、H、R、N、D、T)、T143(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D)、A144(G、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、R145(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、N、D、T)、M146(G、A、L、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、H147(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、R、N、D、T)、I162(G、A、L、M、F、W、K、Q、E、S、P、V、C、Y、H、R、N、D、T)、E163(G、A、L、M、F、W、K、Q、S、P、V、I、C、Y、H、R、N、D、T)、T164(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D)、W165(G、A、L、M、F、K、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、C166(G、A、L、M、F、W、K、Q、E、S、P、V、I、Y、H、R、N、D、T)、Q167(G、A、L、M、F、W、K、E、S、P、V、I、C、Y、H、R、N、D、T)、S168(G、A、L、M、F、W、K、Q、E、P、V、I、C、Y、H、R、N、D、T)、E169(G、A、L、M、F、W、K、Q、S、P、V、I、C、Y、H、R、N、D、T)、G170(A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、R171(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、N、D、T)、I172(G、A、L、M、F、W、K、Q、E、S、P、V、C、Y、H、R、N、D、T)、G173(A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、T174(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D)、R175(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、N、D、T)、R176(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、N、D、T)、D177(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、T)、W178(G、A、L、M、F、K、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、R191(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、N、D、T)、A192(G、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、T193(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D)、S194(G、A、L、M、F、W、K、Q、E、P、V、I、C、Y、H、R、N、D、T)、K195(G、A、L、M、F、W、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、W196(G、A、L、M、F、K、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、V197(G、A、L、M、F、W、K、Q、E、S、P、I、C、Y、H、R、N、D、T)、M198(G、A、L、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、M199(G、A、L、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、Q207(G、A、L、M、F、W、K、E、S、P、V、I、C、Y、H、R、N、D、T)、V209(G、A、L、M、F、W、K、Q、E、S、P、I、C、Y、H、R、N、D、T)、S210(G、A、L、M、F、W、K、Q、E、P、V、I、C、Y、H、R、N、D、T)、D212(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、T)、V213(G、A、L、M、F、W、K、Q、E、S、P、I、C、Y、H、R、N、D、T)、R214(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、N、D、T)、D215(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、T)、E216(G、A、L、M、F、W、K、Q、S、P、V、I、C、Y、H、R、N、D、T)、Y217(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、H、R、N、D、T)、L218(G、A、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、V219(G、A、L、M、F、W、K、Q、E、S、P、I、C、Y、H、R、N、D、T)、F220(G、A、L、M、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、C221(G、A、L、M、F、W、K、Q、E、S、P、V、I、Y、H、R、N、D、T)、P222(G、A、L、M、F、W、K、Q、E、S、V、I、C、Y、H、R、N、D、T)、Q223(G,A,L,M,F,W,K,E,S,P,V,I,C,Y,H,R,N,D,T), R226(G,A,L,M,F,W,K, Q, E, S, P, V, I, C, Y, H, N, D, T), D262 (G, A, L, M, F, W, K, Q, E, S, P, V, I, C, Y, H, R, N, T), M263 (G, A, L, F, W, K, Q, E, S, P, V, I, C, Y, H, R, N, D, T), N264 (G, A, L, M, F ,W,K,Q,E,S,P,V,I,C,Y,H,R,D,T),H266(G,A,L,M,F,W,K,Q,E,S,P,V,I,C,Y (G, A, L, M, F, W, K, Q, E, S, P, I, C, Y, H, R, N, D, T), V270 (G, A, L, M, F, W, K, Q, E, S, P, I, C, Y, H, R, N, D, T), and Y297 (G, A, L, M, F, W, K, Q, E, S, P, V, I, C, H, R, N, D, T), wherein the positions of the amino acid substitutions are relative to those of SEQ ID NO:

1. ID NO: 1 provides the amino acid sequence position; or A DNA sequence encoding a FatA acyl-ACP thioesterase comprising at least a first amino acid substitution selected from the group consisting of: R176A, R176C, R176V, Y217L, L218C, S168R, G114S, F123N, R191C, C221F, N269Y, F123C, S168C, F220H, V121N, N269W, A118V and A144Y, wherein the position of the amino acid substitution is relative to the position of the amino acid sequence provided as SEQ ID NO:

1.

17. The recombinant polynucleotide of claim 16, wherein the FatA acyl-ACP thioesterase comprises at least 2, at least 3, at least 4, at least 5, at least 6, or at least 7 of the amino acid substitutions R176A, R176C, R176V, Y217L, L218C, S168R, G114S, F123N, R191C, C221F, N269Y, F123C, S168C, F220H, V121N, N269W, A118V, and A144Y, wherein the positions of the amino acid substitutions are relative to the positions of the amino acid sequence provided as SEQ ID NO:

1.

18. The recombinant polynucleotide of claim 16 or 17, wherein the FatA acyl-ACP thioesterase comprises at least one pair of amino acid substitutions selected from the group consisting of: R176A and R191C, R176C and R191C, and R176V and R191C, wherein the positions of the amino acid substitutions are relative to the positions of the amino acid sequence provided as SEQ ID NO:

1.

19. The recombinant polynucleotide according to claim 16, 17 or 18, further comprising: (ii) at least one additional region operably linked to a plant-operable promoter, the region encoding a herbicide tolerance enzyme selected from the group consisting of: hydroxyphenylpyruvate dioxygenase (HPPD), 5-enolpyruvylshikimate-3-phosphate synthase (EPSPS), glyphosate acetyltransferase (GAT), cytochrome P450, phosphinothricin acetyltransferase (PAT), acetolactate synthase (ALS), protoporphyrinogen oxidase (PPO), hydroxyphenylpyruvate dioxygenase (HPPD) and a dicamba degrading enzyme.

20. A plant cell tolerant to a FatA acyl-ACP thioesterase inhibiting herbicide, the plant cell comprising The recombinant polynucleotide according to claim 16, or A DNA sequence encoding a FatA acyl-ACP thioesterase comprising at least a first amino acid substitution, said amino acid substitution being selected from the group consisting of: S76(G, A, L, M, F, W, K, Q, E, P, V, I, C, Y, H, R, N, D, T), L77(G, A, M, F, W, K, Q, E, S, P, V, I, C, Y, H, R, N, D, T), T78(G, A, L, M, F, W, K, Q, E, S, P, V, I, C, Y, H, R, N, D), D80(G, A, L, M, F, W, K, Q, E, S, P, V, I, C, Y, H, R, N, T), G81(A, L, M, F, W, K, Q, E, S, P, V, I, C, Y, H, R, N, D, T), L82(G, A, M, F, W, K, Q, E, S, P, V, I, C, Y, H, R, N, D, T), S83(G, A, L, M, F, W, K, Q, E, P, V, I, C, Y, H, R, N, D, T), Y84(G, A, L, M, F, W, K, Q, E, S, P, V, I, C, H, R, N, D, T), K85(G, A, L, M, F, W, Q, E, S, P, V, I, C, Y, H, R, N, D, T), E86(G, A, L, M, F, W, K, Q, S, P, V, I, C, Y, H, R, N, D, T), F88(G, A, L, M, W, K, Q, E, S, P, V, I, C, Y, H, R, N, D, T), I106(G, A, L, M, F, W, K, Q, E, S, P, V, C, Y, H, R, N, D, T), A107(G, L, M, F, W, K, Q, E, S, P, V, I, C, Y, H, R, N, D, T), N108(G, A, L, M, F, W, K, Q, E, S, P, V, I, C, Y, H, R, D, T), L109(G, A, M, F, W, K, Q, E, S, P, V, I, C, Y, H, R, N, D, T), L110(G, A, M, F, W, K, Q, E, S, P, V, I, C, Y, H, R, N, D, T), Q111(G, A, L, M, F, W, K, E, S, P, V, I, C, Y, H, R, N, D, T), E112(G, A, L, M, F, W, K, Q, S, P, V, I, C, Y, H, R, N, D, T), V113(G, A, L, M, F, W, K, Q, E, S, P, I, C, Y, H, R, N, D, T), G114(A, L, M, F, W, K, Q, E, S, P, V, I, C, Y, H, R, N, D, T), C115(G, A, L, M, F, W, K, Q, E, S, P, V, I, Y, H, R, N, D, T), N116(G, A, L, M, F, W, K, Q, E, S, P, V, I, C, Y, H,R、D、T)、H117(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、R、N、D、T)、A118(G、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、Q119(G、A、L、M、F、W、K、E、S、P、V、I、C、Y、H、R、N、D、T)、S120(G、A、L、M、F、W、K、Q、E、P、V、I、C、Y、H、R、N、D、T)、V121(G、A、L、M、F、W、K、Q、E、S、P、I、C、Y、H、R、N、D、T)、G122(A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、F123(G、A、L、M、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、S124(G、A、L、M、F、W、K、Q、E、P、V、I、C、Y、H、R、N、D、T)、T125(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D)、D126(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、T)、G127(A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、F128(G、A、L、M、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、A129(G、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、T130(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D)、T131(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D)、T132(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D)、T133(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D)、M134(G、A、L、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、R135(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、N、D、T)、L139(G、A、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、I140(G、A、L、M、F、W、K、Q、E、S、P、V、C、Y、H、R、N、D、T)、W141(G、A、L、M、F、K、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、V142(G、A、L、M、F、W、K、Q、E、S、P、I、C、Y、H、R、N、D、T)、T143(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D)、A144(G、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、R145(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、N、D、T)、M146(G、A、L、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、H147(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、R、N、D、T)、I162(G、A、L、M、F、W、K、Q、E、S、P、V、C、Y、H、R、N、D、T)、E163(G、A、L、M、F、W、K、Q、S、P、V、I、C、Y、H、R、N、D、T)、T164(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D)、W165(G、A、L、M、F、K、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、C166(G、A、L、M、F、W、K、Q、E、S、P、V、I、Y、H、R、N、D、T)、Q167(G、A、L、M、F、W、K、E、S、P、V、I、C、Y、H、R、N、D、T)、S168(G、A、L、M、F、W、K、Q、E、P、V、I、C、Y、H、R、N、D、T)、E169(G、A、L、M、F、W、K、Q、S、P、V、I、C、Y、H、R、N、D、T)、G170(A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、R171(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、N、D、T)、I172(G、A、L、M、F、W、K、Q、E、S、P、V、C、Y、H、R、N、D、T)、G173(A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、T174(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D)、R175(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、N、D、T)、R176(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、N、D、T)、D177(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、T)、W178(G、A、L、M、F、K、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、R191(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、N、D、T)、A192(G、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、T193(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D)、S194(G、A、L、M、F、W、K、Q、E、P、V、I、C、Y、H、R、N、D、T)、K195(G、A、L、M、F、W、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、W196(G、A、L、M、F、K、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、V197(G、A、L、M、F、W、K、Q、E、S、P、I、C、Y、H、R、N、D、T)、M198(G、A、L、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、M199(G、A、L、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、Q207(G、A、L、M、F、W、K、E、S、P、V、I、C、Y、H、R、N、D、T)、V209(G、A、L、M、F、W、K、Q、E、S、P、I、C、Y、H、R、N、D、T)、S210(G、A、L、M、F、W、K、Q、E、P、V、I、C、Y、H、R、N、D、T)、D212(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、T)、V213(G、A、L、M、F、W、K、Q、E、S、P、I、C、Y、H、R、N、D、T)、R214(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、N、D、T)、D215(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、T)、E216(G、A、L、M、F、W、K、Q、S、P、V、I、C、Y、H、R、N、D、T)、Y217(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、H、R、N、D、T)、L218(G、A、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、V219(G、A、L、M、F、W、K、Q、E、S、P、I、C、Y、H、R、N、D、T)、F220(G、A、L、M、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、C221(G、A、L、M、F、W、K、Q、E、S、P、V、I、Y、H、R、N、D、T)、P222(G、A、L、M、F、W、K、Q、E、S、V、I、C、Y、H、R、N、D、T)、Q223(G,A,L,M,F,W,K,E,S,P,V,I,C,Y,H,R,N,D,T), R226(G,A,L,M,F,W,K, Q, E, S, P, V, I, C, Y, H, N, D, T), D262 (G, A, L, M, F, W, K, Q, E, S, P, V, I, C, Y, H, R, N, T), M263 (G, A, L, F, W, K, Q, E, S, P, V, I, C, Y, H, R, N, D, T), N264 (G, A, L, M, F ,W,K,Q,E,S,P,V,I,C,Y,H,R,D,T),H266(G,A,L,M,F,W,K,Q,E,S,P,V,I,C,Y (G, A, L, M, F, W, K, Q, E, S, P, I, C, Y, H, R, N, D, T), V270 (G, A, L, M, F, W, K, Q, E, S, P, I, C, Y, H, R, N, D, T), and Y297 (G, A, L, M, F, W, K, Q, E, S, P, V, I, C, H, R, N, D, T), wherein the positions of the amino acid substitutions are relative to those of SEQ ID NO:

1. ID NO: 1, and wherein the substitution increases tolerance to at least one FatA acyl-ACP thioesterase inhibiting herbicide; or A DNA sequence encoding a FatA acyl-ACP thioesterase comprising at least a first amino acid substitution selected from the group consisting of: R176A, R176C, R176V, Y217L, L218C, S168R, G114S, F123N, R191C, C221F, N269Y, F123C, S168C, F220H, V121N, N269W, A118V and A144Y, wherein the position of the amino acid substitution is relative to the position of the amino acid sequence provided as SEQ ID NO:

1.

21. The plant cell of claim 20, wherein the DNA sequence encoding the FatA acyl-ACP thioesterase comprising at least a first amino acid substitution is a native FatA acyl-ACP thioesterase that has been edited to include the substitution.

22. The method of claim 20 or 21, wherein the substitutions comprise at least two amino acid substitutions selected from the group consisting of: R176A, R176C, R176V, Y217L, L218C, S168R, G114S, F123N, R191C, C221F, N269Y, F123C, S168C, F220H, V121N, N269W, A118V, and A144Y, wherein the positions of the amino acid substitutions are relative to the position of the amino acid sequence provided as SEQ ID NO:

1.

23. A FatA acyl-ACP thioesterase, which comprises at least a first amino acid substitution selected from the group consisting of: S76(G, A, L, M, F, W, K, Q, E, P, V, I, C, Y, H, R, N, D, T), L77(G, A, M, F, W, K, Q, E, S, P, V, I, C, Y, H, R, N, D, T), T78(G, A, L, M, F, W, K, Q, E, S, P, V, I, C, Y, H, R, N, D), D80(G, A, L, M, F, W, K, Q, E, S, P, V, I, C, Y, H, R, N, T), G81(A, L, M, F, W, K, Q, E, S, P, V, I, C, Y, H, R, N, D, T), L82(G, A, M, F, W, K, Q, E, S, P, V, I, C, Y, H, R, N, D, T), S83(G, A, L, M, F, W, K, Q, E, P, V, I, C, Y, H, R, N, D, T), Y84(G, A, L, M, F, W, K, Q, E, S, P, V, I, C, H, R, N, D, T), K85(G, A, L, M, F, W, Q, E, S, P, V, I, C, Y, H, R, N, D, T), E86(G, A, L, M, F, W, K, Q, S, P, V, I, C, Y, H, R, N, D, T), F88(G, A, L, M, W, K, Q, E, S, P, V, I, C, Y, H, R, N, D, T), 1106(G, A, L, M, F, W, K, Q, E, S, P, V, C, Y, H, R, N, D, T), A107(G, L, M, F, W, K, Q, E, S, P, V, I, C, Y, H, R, N, D, T), N108(G, A, L, M, F, W, K, Q, E, S, P, V, I, C, Y, H, R, D, T), L109(G, A, M, F, W, K, Q, E, S, P, V, I, C, Y, H, R, N, D, T), L110(G, A, M, F, W, K, Q, E, S, P, V, I, C, Y, H, R, N, D, T), Q111(G, A, L, M, F, W, K, E, S, P, V, I, C, Y, H, R, N, D, T), E112(G, A, L, M, F, W, K, Q, S, P, V, I, C, Y, H, R, N, D, T), V113(G, A, L, M, F, W, K, Q, E, S, P, I, C, Y, H, R, N, D, T), G114(A, L, M, F, W, K, Q, E, S, P, V, I, C, Y, H, R, N, D, T), C115(G, A, L, M, F, W, K, Q, E, S, P, V, I, Y, H, R, N, D, T), N116(G, A, L, M, F, W, K, Q, E, S, P, V, I, C, Y, H, R, D, T),H117(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、R、N、D、T)、A118(G、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、Q119(G、A、L、M、F、W、K、E、S、P、V、I、C、Y、H、R、N、D、T)、S120(G、A、L、M、F、W、K、Q、E、P、V、I、C、Y、H、R、N、D、T)、V121(G、A、L、M、F、W、K、Q、E、S、P、I、C、Y、H、R、N、D、T)、G122(A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、F123(G、A、L、M、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、S124(G、A、L、M、F、W、K、Q、E、P、V、I、C、Y、H、R、N、D、T)、T125(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D)、D126(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、T)、G127(A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、F128(G、A、L、M、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、A129(G、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、T130(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D)、T131(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D)、T132(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D)、T133(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D)、M134(G、A、L、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、R135(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、N、D、T)、L139(G、A、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、I140(G、A、L、M、F、W、K、Q、E、S、P、V、C、Y、H、R、N、D、T)、W141(G、A、L、M、F、K、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、V142(G、A、L、M、F、W、K、Q、E、S、P、I、C、Y、H、R、N、D、T)、T143(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D)、A144(G、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、R145(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、N、D、T)、M146(G、A、L、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、H147(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、R、N、D、T)、I162(G、A、L、M、F、W、K、Q、E、S、P、V、C、Y、H、R、N、D、T)、E163(G、A、L、M、F、W、K、Q、S、P、V、I、C、Y、H、R、N、D、T)、T164(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D)、W165(G、A、L、M、F、K、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、C166(G、A、L、M、F、W、K、Q、E、S、P、V、I、Y、H、R、N、D、T)、Q167(G、A、L、M、F、W、K、E、S、P、V、I、C、Y、H、R、N、D、T)、S168(G、A、L、M、F、W、K、Q、E、P、V、I、C、Y、H、R、N、D、T)、E169(G、A、L、M、F、W、K、Q、S、P、V、I、C、Y、H、R、N、D、T)、G170(A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、R171(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、N、D、T)、I172(G、A、L、M、F、W、K、Q、E、S、P、V、C、Y、H、R、N、D、T)、G173(A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、T174(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D)、R175(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、N、D、T)、R176(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、N、D、T)、D177(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、T)、W178(G、A、L、M、F、K、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、R191(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、N、D、T)、A192(G、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、T193(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D)、S194(G、A、L、M、F、W、K、Q、E、P、V、I、C、Y、H、R、N、D、T)、K195(G、A、L、M、F、W、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、W196(G、A、L、M、F、K、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、V197(G、A、L、M、F、W、K、Q、E、S、P、I、C、Y、H、R、N、D、T)、M198(G、A、L、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、M199(G、A、L、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、Q207(G、A、L、M、F、W、K、E、S、P、V、I、C、Y、H、R、N、D、T)、V209(G、A、L、M、F、W、K、Q、E、S、P、I、C、Y、H、R、N、D、T)、S210(G、A、L、M、F、W、K、Q、E、P、V、I、C、Y、H、R、N、D、T)、D212(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、T)、V213(G、A、L、M、F、W、K、Q、E、S、P、I、C、Y、H、R、N、D、T)、R214(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、N、D、T)、D215(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、T)、E216(G、A、L、M、F、W、K、Q、S、P、V、I、C、Y、H、R、N、D、T)、Y217(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、H、R、N、D、T)、L218(G、A、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、V219(G、A、L、M、F、W、K、Q、E、S、P、I、C、Y、H、R、N、D、T)、F220(G、A、L、M、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、C221(G、A、L、M、F、W、K、Q、E、S、P、V、I、Y、H、R、N、D、T)、P222(G、A、L、M、F、W、K、Q、E、S、V、I、C、Y、H、R、N、D、T)、Q223(G、A、L, M, F, W, K, E, S, P, V, I, C, Y, H, R, N, D, T), R226 (G, A, L, M, F, W, K, Q, E, S, P, V, I, C, Y, H, N, D, T), D262 (G, A, L, M, F, W, K, Q, E, S, P, V, I, C, Y, H, R, N, T), M 263(G,A,L,F,W,K,Q,E,S,P,V,I,C,Y,H,R,N,D,T), N264(G,A,L,M,F,W,K, Q, E, S, P, V, I, C, Y, H, R, D, T), H266 (G, A, L, M, F, W, K, Q, E, S, P, V, I, C, Y, R, N , A, L, M, F, W, K, Q, E, S, P, I, C, Y, H, R, N, D, T), V267 (G, A, L, M, F, W, K, Q, E, S, P, I, C, Y, H, R, N, D, T), N268 (G, A, L, M, F, W, K, Q, E, S, P, V, I, C, Y, H, R, D, T), N269 (G, A, L, M, F, W, K, Q, E, S, P, V, I, C, Y, H, R, N, D, T), V270 (G, A, L, M, F, W, K, Q, E, S, P, I, C, Y, H, R, N, D, T), and Y297 (G, A, L, M, F, W, K, Q, E, S, P, V, I, C, H, R, N, D, T), wherein the position of the amino acid substitution is relative to the position of the amino acid sequence provided as SEQ ID NO: 1; or, R176A, R176C, R176V, Y217L, L218C, S168R, G114S, F123N, R191C, C221F, N269Y, F123C, S168C, F220H, V121N, N269W, A118V and A144Y, wherein the position of the amino acid substitution is relative to the position of the amino acid sequence provided as SEQ ID NQ:1, and wherein the FatA acyl-ACP thioesterase is tolerant to a FatA acyl-ACP thioesterase inhibiting herbicide.

24. The FatA acyl-ACP thioesterase of claim 23, wherein the FatA acyl-ACP thioesterase comprises at least 2, at least 3, at least 4, at least 5, at least 6, or at least 7 of the amino acid substitutions.

25. The FatA acyl-ACP thioesterase of claim 23, wherein the FatA acyl-ACP thioesterase comprises an amino acid substitution selected from the group consisting of: R176A and R191C, R176C and R191C, and R176V and R191C.

26. A FatA acyl-ACP thioesterase having an amino acid sequence selected from the group consisting of SEQ ID NQs: 15-19 or a non-natural amino acid sequence having at least 70%, at least 71%, at least 72%, at least 73%, at least 74%, at least 75%, at least 76%, at least 77%, at least 78%, at least 79%, at least 80%, at least 81%, at least 82%, at least 83%, at least 84%, at least 85%, at least 86%, at least 87%, at least 88%, at least 89%, at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98%, and at least 99% sequence identity thereto.

27. A recombinant polynucleotide comprising: a nucleic acid encoding a DNA modifying enzyme; and Nucleic acid encoding at least one guide RNA (gRNA), wherein the at least one guide RNA mediates at least one modification to a FatA acyl-ACP thioesterase.

28. The recombinant polynucleotide of claim 27, wherein the at least one gRNA mediates at least a first amino acid substitution selected from the group consisting of: S76(G、A、L、M、F、W、K、Q、E、P、V、I、C、Y、H、R、N、D、T)、L77(G、A、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、T78(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D)、D80(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、T)、G81(A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、L82(G、A、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、S83(G、A、L、M、F、W、K、Q、E、P、V、I、C、Y、H、R、N、D、T)、Y84(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、H、R、N、D、T)、K85(G、A、L、M、F、W、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、E86(G、A、L、M、F、W、K、Q、S、P、V、I、C、Y、H、R、N、D、T)、F88(G、A、L、M、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、I106(G、A、L、M、F、W、K、Q、E、S、P、V、C、Y、H、R、N、D、T)、A107(G、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、N108(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、D、T)、L109(G、A、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、L110(G、A、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、Q111(G、A、L、M、F、W、K、E、S、P、V、I、C、Y、H、R、N、D、T)、E112(G、A、L、M、F、W、K、Q、S、P、V、I、C、Y、H、R、N、D、T)、V113(G、A、L、M、F、W、K、Q、E、S、P、I、C、Y、H、R、N、D、T)、G114(A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、C115(G、A、L、M、F、W、K、Q、E、S、P、V、I、Y、H、R、N、D、T)、N116(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、D、T)、H117(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、R、N、D、T)、A118(G、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、Q119(G、A、L、M、F、W、K、E、S、P、V、I、C、Y、H、R、N、D、T)、S120(G、A、L、M、F、W、K、Q、E、P、V、I、C、Y、H、R、N、D、T)、V121(G、A、L、M、F、W、K、Q、E、S、P、I、C、Y、H、R、N、D、T)、G122(A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、F123(G、A、L、M、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、S124(G、A、L、M、F、W、K、Q、E、P、V、I、C、Y、H、R、N、D、T)、T125(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D)、D126(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、T)、G127(A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、F128(G、A、L、M、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、A129(G、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、T130(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D)、T131(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D)、T132(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D)、T133(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D)、M134(G、A、L、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、R135(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、N、D、T)、L139(G、A、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、I140(G、A、L、M、F、W、K、Q、E、S、P、V、C、Y、H、R、N、D、T)、W141(G、A、L、M、F、K、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、V142(G、A、L、M、F、W、K、Q、E、S、P、I、C、Y、H、R、N、D、T)、T143(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D)、A144(G、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、R145(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、N、D、T)、M146(G、A、L、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、H147(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、R、N、D、T)、I162(G、A、L、M、F、W、K、Q、E、S、P、V、C、Y、H、R、N、D、T)、E163(G、A、L、M、F、W、K、Q、S、P、V、I、C、Y、H、R、N、D、T)、T164(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D)、W165(G、A、L、M、F、K、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、C166(G、A、L、M、F、W、K、Q、E、S、P、V、I、Y、H、R、N、D、T)、Q167(G、A、L、M、F、W、K、E、S、P、V、I、C、Y、H、R、N、D、T)、S168(G、A、L、M、F、W、K、Q、E、P、V、I、C、Y、H、R、N、D、T)、E169(G、A、L、M、F、W、K、Q、S、P、V、I、C、Y、H、R、N、D、T)、G170(A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、R171(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、N、D、T)、I172(G、A、L、M、F、W、K、Q、E、S、P、V、C、Y、H、R、N、D、T)、G173(A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、T174(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D)、R175(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、N、D、T)、R176(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、N、D、T)、D177(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、T)、W178(G、A、L、M、F、K、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、R191(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、N、D、T)、A192(G、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、T193(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D)、S194(G、A、L、M、F、W、K、Q、E、P、V、I、C、Y、H、R、N、D、T)、K195(G、A、L、M、F、W、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、W196(G、A、L、M、F、K、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、V197(G、A、L、M、F、W、K、Q、E、S、P、I、C、Y、H、R、N、D、T)、M198(G、A、L、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、M199(G、A、L、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、Q207(G、A、L、M、F、W、K、E、S、P、V、I、C、Y、H、R、N、D、T)、V209(G、A、L、M、F、W、K、Q、E、S、P、I、C、Y、H、R、N、D、T)、S210(G、A、L、M、F、W、K、Q、E、P、V、I、C、Y、H、R、N、D、T)、D212(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、T)、V213(G、A、L、M、F、W、K、Q、E、S、P、I、C、Y、H、R、N、D、T)、R214(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、N、D、T)、D215(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、T)、E216(G、A、L、M、F、W、K、Q、S、P、V、I、C、Y、H、R、N、D、T)、Y217(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、H、R、N、D、T)、L218(G、A、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、V219(G、A、L、M、F、W、K、Q、E、S、P、I、C、Y、H、R、N、D、T)、F220(G、A、L、M、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、C221(G、A、L、M、F、W、K、Q、E、S、P、V、I、Y、H、R、N、D、T)、P222(G、A、L、M、F、W、K、Q、E、S、V、I、C、Y、H、R、N、D、T)、Q223(G、A、L、M、F、W、K、E、S、P、V、I、C、Y、H、R、N、D、T)、R226(G、A、L, M, F, W, K, Q, E, S, P, V, I, C, Y, H, N, D, T), D262 (G, A, L, M, F, W, K, Q, E, S, P, V, I, C, Y, H, R, N, T), M263 (G, A, L, F, W, K, Q, E, S, P, V, I, C, Y, H , R, N, D, T), N264 (G, A, L, M, F, W, K, Q, E, S, P, V, I, C, Y, H, R, D, T), H266 (G, A, L, M, F, W, K, Q, E, S, P, V, I, C, Y, R, N, D, T), V267 (G, A, L, M, F, W , A, L, M, F, W, K, Q, E, S, P, I, C, Y, H, R, N, D, T), N268 (G, A, L, M, F, W, K, Q, E, S, P, V, I, C, Y, H, R, D, T), N269 (G, A, L, M, F, W, K, Q, E, S, P, V, I, C, Y, H, R, N, D, T), V270 (G, A, L, M, F, W, K, Q, E, S, P, I, C, Y, H, R, N, D, T), and Y297 (G, A, L, M, F, W, K, Q, E, S, P, V, I, C, H, R, N, D, T), wherein the position of the amino acid substitution is relative to the position of the amino acid sequence provided as SEQ ID NO: 1; or, R176A, R176C, R176V, Y217L, L218C, S168R, G114S, F123N, R191C, C221F, N269Y, F123C, S168C, F220H, V121N, N269W, A118V and A144Y, wherein the position of the amino acid substitution is relative to the position of the amino acid sequence provided as SEQ ID NO:

1.

29. The recombinant polynucleotide of claim 28, wherein the at least one gRNA mediates at least 2, at least 3, at least 4, at least 5, at least 6, or at least 7 of the amino acid substitutions.

30. The recombinant polynucleotide of claim 28, wherein the at least one gRNA mediates at least one pair of amino acid substitutions selected from the group consisting of: R176A and R191C, R176C and R191C, and R176V and R191C.

31. A method for producing a plant tolerant to a FatA acyl-ACP thioesterase inhibiting herbicide, the method comprising: a) transforming at least one recombinant polynucleotide into a plant cell or plant tissue, wherein the at least one recombinant polynucleotide comprises a nucleic acid encoding a DNA modifying enzyme, a nucleic acid encoding at least one guide RNA (gRNA), wherein the at least one guide RNA mediates at least one modification of a FatA acyl-ACP thioesterase; and b) regenerating the plant cell or plant tissue into a TO plant having T1 seeds, wherein the T1 seeds can be regenerated to produce an edited plant that is tolerant to a FatA acyl-ACP thioesterase inhibiting herbicide.

32. The method of claim 31, wherein the at least one gRNA mediates at least a first amino acid substitution selected from the group consisting of: S76(G、A、L、M、F、W、K、Q、E、P、V、I、C、Y、H、R、N、D、T)、L77(G、A、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、T78(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D)、D80(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、T)、G81(A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、L82(G、A、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、S83(G、A、L、M、F、W、K、Q、E、P、V、I、C、Y、H、R、N、D、T)、Y84(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、H、R、N、D、T)、K85(G、A、L、M、F、W、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、E86(G、A、L、M、F、W、K、Q、S、P、V、I、C、Y、H、R、N、D、T)、F88(G、A、L、M、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、I106(G、A、L、M、F、W、K、Q、E、S、P、V、C、Y、H、R、N、D、T)、A107(G、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、N108(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、D、T)、L109(G、A、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、L110(G、A、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、Q111(G、A、L、M、F、W、K、E、S、P、V、I、C、Y、H、R、N、D、T)、E112(G、A、L、M、F、W、K、Q、S、P、V、I、C、Y、H、R、N、D、T)、V113(G、A、L、M、F、W、K、Q、E、S、P、I、C、Y、H、R、N、D、T)、G114(A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、C115(G、A、L、M、F、W、K、Q、E、S、P、V、I、Y、H、R、N、D、T)、N116(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、D、T)、H117(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、R、N、D、T)、A118(G、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、Q119(G、A、L、M、F、W、K、E、S、P、V、I、C、Y、H、R、N、D、T)、S120(G、A、L、M、F、W、K、Q、E、P、V、I、C、Y、H、R、N、D、T)、V121(G、A、L、M、F、W、K、Q、E、S、P、I、C、Y、H、R、N、D、T)、G122(A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、F123(G、A、L、M、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、S124(G、A、L、M、F、W、K、Q、E、P、V、I、C、Y、H、R、N、D、T)、T125(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D)、D126(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、T)、G127(A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、F128(G、A、L、M、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、A129(G、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、T130(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D)、T131(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D)、T132(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D)、T133(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D)、M134(G、A、L、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、R135(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、N、D、T)、L139(G、A、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、I140(G、A、L、M、F、W、K、Q、E、S、P、V、C、Y、H、R、N、D、T)、W141(G、A、L、M、F、K、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、V142(G、A、L、M、F、W、K、Q、E、S、P、I、C、Y、H、R、N、D、T)、T143(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D)、A144(G、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、R145(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、N、D、T)、M146(G、A、L、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、H147(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、R、N、D、T)、I162(G、A、L、M、F、W、K、Q、E、S、P、V、C、Y、H、R、N、D、T)、E163(G、A、L、M、F、W、K、Q、S、P、V、I、C、Y、H、R、N、D、T)、T164(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D)、W165(G、A、L、M、F、K、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、C166(G、A、L、M、F、W、K、Q、E、S、P、V、I、Y、H、R、N、D、T)、Q167(G、A、L、M、F、W、K、E、S、P、V、I、C、Y、H、R、N、D、T)、S168(G、A、L、M、F、W、K、Q、E、P、V、I、C、Y、H、R、N、D、T)、E169(G、A、L、M、F、W、K、Q、S、P、V、I、C、Y、H、R、N、D、T)、G170(A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、R171(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、N、D、T)、I172(G、A、L、M、F、W、K、Q、E、S、P、V、C、Y、H、R、N、D、T)、G173(A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、T174(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D)、R175(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、N、D、T)、R176(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、N、D、T)、D177(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、T)、W178(G、A、L、M、F、K、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、R191(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、N、D、T)、A192(G、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、T193(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D)、S194(G、A、L、M、F、W、K、Q、E、P、V、I、C、Y、H、R、N、D、T)、K195(G、A、L、M、F、W、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、W196(G、A、L、M、F、K、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、V197(G、A、L、M、F、W、K、Q、E、S、P、I、C、Y、H、R、N、D、T)、M198(G、A、L、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、M199(G、A、L、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、Q207(G、A、L、M、F、W、K、E、S、P、V、I、C、Y、H、R、N、D、T)、V209(G、A、L、M、F、W、K、Q、E、S、P、I、C、Y、H、R、N、D、T)、S210(G、A、L、M、F、W、K、Q、E、P、V、I、C、Y、H、R、N、D、T)、D212(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、T)、V213(G、A、L、M、F、W、K、Q、E、S、P、I、C、Y、H、R、N、D、T)、R214(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、N、D、T)、D215(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、T)、E216(G、A、L、M、F、W、K、Q、S、P、V、I、C、Y、H、R、N、D、T)、Y217(G、A、L、M、F、W、K、Q、E、S、P、V、I、C、H、R、N、D、T)、L218(G、A、M、F、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、V219(G、A、L、M、F、W、K、Q、E、S、P、I、C、Y、H、R、N、D、T)、F220(G、A、L、M、W、K、Q、E、S、P、V、I、C、Y、H、R、N、D、T)、C221(G、A、L、M、F、W、K、Q、E、S、P、V、I、Y、H、R、N、D、T)、P222(G、A、L、M、F、W、K、Q、E、S、V、I、C、Y、H、R、N、D、T)、Q223(G、A、L、M、F、W、K、E、S、P、V、I、C、Y、H、R、N、D、T)、R226(G、A、L, M, F, W, K, Q, E, S, P, V, I, C, Y, H, N, D, T), D262 (G, A, L, M, F, W, K, Q, E, S, P, V, I, C, Y, H, R, N, T), M263 (G, A, L, F, W, K, Q, E, S, P, V, I, C, Y, H , R, N, D, T), N264 (G, A, L, M, F, W, K, Q, E, S, P, V, I, C, Y, H, R, D, T), H266 (G, A, L, M, F, W, K, Q, E, S, P, V, I, C, Y, R, N, D, T), V267 (G, A, L, M, F, W , A, L, M, F, W, K, Q, E, S, P, I, C, Y, H, R, N, D, T), N268 (G, A, L, M, F, W, K, Q, E, S, P, V, I, C, Y, H, R, D, T), N269 (G, A, L, M, F, W, K, Q, E, S, P, V, I, C, Y, H, R, N, D, T), V270 (G, A, L, M, F, W, K, Q, E, S, P, I, C, Y, H, R, N, D, T), and Y297 (G, A, L, M, F, W, K, Q, E, S, P, V, I, C, H, R, N, D, T), wherein the position of the amino acid substitution is relative to the position of the amino acid sequence provided as SEQ ID NO: 1; or, R176A, R176C, R176V, Y217L, L218C, S168R, G114S, F123N, R191C, C221F, N269Y, F123C, S168C, F220H, V121N, N269W, A118V and A144Y, wherein the position of the amino acid substitution is relative to the position of the amino acid sequence provided as SEQ ID NO:

1.

33. The method of claim 32, wherein the at least one gRNA mediates at least 2, at least 3, at least 4, at least 5, at least 6, or at least 7 of the amino acid substitutions.

34. The method of claim 33, wherein the at least one gRNA mediates at least one pair of amino acid substitutions selected from the group consisting of: R176A and R191C, R176C and R191C, and R176V and R191C.

35. Use of recombinant FatA acyl-ACP thioesterase in an in vitro screening method for identifying FatA acyl-ACP thioesterase-inhibiting herbicides.

Citation Information

Patent Citations

  • Mutant hydroxyphenylpyruvate dioxygenase polypeptides and methods of use

    CN102348802A

  • Plastid transit peptide sequences for efficient plastid targeting

    US20020178467A1